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Foreword
I am honoured to be asked to write the Foreword for this Practical Guide and Atlas for the Diagnosis of Fungal 
Infections. Fungal infections are ubiquitous and often result in much misery and suffering. Immunocompromised 
patients in particular are at risk of such infections. Advances in healthcare resulting in an increasing population of 
immunocompromised individuals further exacerbate the risk of fungal infection related morbidity and mortality.
These infections, however, are frequently underdiagnosed and hence under-recognised. The true burden of fungal 
infections particularly in resource-limited countries is thus unknown. Without such baseline information it is difficult 
to assess the impact that such infections may have on the health of the population and to develop strategies for 
their control. There is thus a great need for tools that can enhance capacity for the diagnosis and control of fungal 
diseases.
This book written by experienced and distinguished experts in the field presents a comprehensive and a very 
practical approach to the laboratory diagnosis of fungal infections. The excellent illustrations and photographs 
accompanied by stepwise practical guidance will assist professionals and students in strengthening diagnosis of 
such infections. They further provide a much-needed guide to the spectrum of fungi associated with infections in 
this part of the world. 
As the number of antifungal agents available and their spectrum of activity increases, so does the need to determine 
the susceptibility of isolates to these agents. Antifungal susceptibility testing is not widespread in resource-limited 
settings. Thus the chapter on antifungal susceptibility testing provides a detailed account of currently available 
susceptibility methodologies to facilitate their implementation. This book furthermore touches upon newer 
techniques that are being introduced for the diagnosis of fungal diseases. It also emphasises the importance of 
safety precautions required in mycology laboratories.
Written at the behest of many students and colleagues requesting guidance in developing capacity for diagnostic 
mycology, this book is timely and much needed. Based on the authors own experience in establishing diagnostic 
mycology in a developing country, it provides clear guidance in a very readable form. It will hopefully contribute 
toward enhancing the detection of fungal diseases and increasing the cadre of enthusiastic medical mycologists 
across the globe.
Rumina Hasan
Abdulaziz Hussainali Shariff Professor 
MBBS, PhD, FRCPath
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Introduction: Why You Need This Atlas
Laboratory diagnosis of fungal infections remains challenging in South East Asia as it is a neglected field in most 
diagnostic centres in the developing world. 
Initial microscopic examination of clinical specimens for the presence of fungal elements followed by growth and 
eventual identification of isolates up to genus and species levels are very basic and important services that must 
be provided by any clinical microbiology laboratory. These services have considerable impact on selection of 
appropriate antifungal therapy and ultimate reduction in morbidity and mortality.
With the realisation of scarcity of this service and expertise in Pakistan, our group decided to produce an atlas for 
use in clinical laboratories to diagnose fungal infections as well as to improve understanding and skills of clinical 
laboratory technologists, residents and junior consultants. 
The editors and authors are hopeful that this atlas will aid in the identification and reporting of fungi in day-to-day 
clinical laboratory practice. 
Abbreviations
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Specimen Collection, Transport and Processing
Kauser Jabeen
The visualisation of fungal elements in invasive and sterile specimens is still considered the gold standard for 
diagnosis of fungal infection. Appropriate specimen collection, transport and processing are essential steps to 
increase the diagnostic sensitivity of these conventional tools.
Prerequisites
• Always consult the SOP manual of the diagnostic laboratory for the particular specimen and test.
• Aim to collect sample in a sterile kit under aseptic conditions.
• Ensure that you have the appropriate swab kit (alcohol swabs, gloves, transportation tube and media). 
• If it is a special or non-routine test, coordinate with the laboratory about specific requirements for collection 
and handling.
• Document the following:
• Patient identifiers (e.g. name, age, medical record number);
• Sample identifiers (e.g. swab, smear, scrape, urine, blood);
• Location and type (e.g. lower limb wound, nail scraping, hair sample);
• Date and time of collection;
• Deviations from standard protocol during collection (e.g. not performed under aseptic conditions if large 
traumatic wound); and
• Relevant clinical information including recent and current antimicrobial therapy.
• Ensure that adequate material (at least 2 ml of bodily fluids) is sent to the lababoratory for proper yield.  
An inadequate specimen may lead to a false negative result.
• Transport the sample within 2 hours and process promptly for optimum recovery of fungi.
• If a delay is anticipated, refrigerate specimens at 4°C (exceptions: blood, bone marrow, CSF and sterile  
tissues should be stored at 35-37°C).
• Ideally, collect specimens as soon as symptoms appear and whenever possible before antifungal therapy  
is initiated.
• Staff must take all precautions to avoid inadvertent contamination of sample as well as for their own  
personal safety.
Specimen Collection and Transport
Swabs and Scrapings
Eye Swab and Scraping 
• Pus and discharge samples can be collected with a cotton wool swab and sent using standard precautions to 
the lab.
• Due to the sensitivity of the region and serious consequences of error, only an experienced ophthalmologist 
collects eye samples (e.g. corneal scrapings, intraocular fluid aspirate and swabs).
• For corneal scrapings, inoculate media plates and prepare slides at the patient’s side. Always contact the 
laboratory to obtain suitable media prior to the procedure. Alternatively, send corneal scrapings directly to the 
laboratory. 
• Intraocular fluid (vitreous and aqueous) is collected using specialised equipment in the operating room.
• If sample is insufficient to perform both smear and inoculation of plates, give priority to culture. 
• In case of contact lens-related infections, send contact lenses, case and cleaning solution to the lab for culture 
as well.
Ear Swab and Scraping
• A physician collects samples from outer and middle ear. Skin scrapings from the external auditory canal are 
preferred. Use a sterile swab stick to collect exudates or debris.
• For deeper ear infections and to avoid damage to the ear drum, an ENT surgeon or experienced physician 
should use a speculum to draw specimen.
Oral Swab
• Using a sterile oral swab collect exudate, pus or debris from the lesion or inflamed area within the oral cavity 
(mucosal surface, lips, inner side of cheek or back of throat).
• A tongue depressor/spatula aids visualisation and avoids contamination from other parts of the mouth.
Low and High Vaginal Swabs
• All mucous discharge should be cleared prior to sample collection.
• A low vaginal swab (LVS) can be collected by the gynaecologist or by the patient herself after receiving proper 
instructions from the physician.
• A gynaecologist collects high vaginal swab (HVS) using a speculum and swab stick. A smear can be made at 
the same time. 
Body Fluids
Blood
• A phlebotomist, physician or nurse can collect an intravenous sample after skin disinfection. 
• In adults, two samples (10 ml each) are submitted in an aerobic and anaerobic blood culture bottle.
• In children, a single sample (4-10 ml) is submitted in a paediatric blood culture bottle.
Antral Washout
• Nasal irrigation or sinus washout samples are obtained under general anaesthesia by an ENT surgeon.
• Sinus contents are sent to the laboratory in a sterile container. 
Lumbar Puncture
• With the patient lying on his side, a single sample (1-10 ml CSF) is drawn by a trained physician after giving 
local anaesthesia and sterile preparation of aspiration site (usually between lower lumbar spines). 
• Sample is sent immediately to laboratory. 
Urine
• Midstream sample is collected by the patient who should be instructed to:
• Collect 10-20 ml midstream urine in a sterile container during the first morning urination. 
• Void the first portion of the urine, and then catch the rest in the container without stopping the stream.
• Ensure hand hygiene prior to collection by washing hands thoroughly with soap and water, and then drying 
with a paper towel. Females should spread labia and clean the urethral meatus in a front-to-back direction.
• Catheter sample is collected by a physician or nurse. 
• Clamp hub of Foley’s catheter distally.
• Clean hub sequentially with pyodine and 70% alcohol.
• Aspirate collected urine from the hub with a sterile needle and syringe. 
• A 24-hour urine collection and Foley’s catheter tip samples are not acceptable.
Tissue
Biopsy
• Surgical collection and punch biopsies may be used for skin lesions.
• If grains are visible to the naked eye, collect aseptically for smear and culture.
• Sterile normal saline should be added to the tissue to prevent drying (just enough to keep tissue moist).
Exudates, Pus and Drainage
• A physician or staff nurse can draw sample from an open wound, ulcer or abscess.
• Always sample a representative part of the lesion. 
• If possible, send several swab samples to the laboratory to allow preparation of fungal smear and inoculation of 
culture plates.
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Open Wound
• Use a sterile syringe to aspirate the wound deeply or alternatively use a sterile swab stick to collect sample, 
especially at base and advancing margins.
• Do not swab dry crusted areas as it is unlikely to yield the causative pathogen.
Ulcer
• Prior to specimen collection from an ulcer, remove all debris and thoroughly wash with normal saline.
• Draw a biopsy specimen from the edge of the wound or, preferably, aspirate with a needle. 
Abscess
• Clean skin with 70% alcohol and palpate point of highest fluctuation. 
• Insert sterile syringe needle and aspirate fluid from the most fluctuant point.
• If needed, obtain sample from base of lesion and abscess wall (scrapings, punch biopsy). 
• Discard syringe needle before transportation to laboratory.
Respiratory Tract Secretions
Sputum
• Patient submits the first morning expectorated sample (optimal) with the following instructions:
• Clean mouth with several rinses of sterile saline or water.
• Cough out 2-5 ml of sputum (not saliva) in a wide-mouthed sterile container. 
• In case of dry cough, perform sputum induction with hypertonic saline nebulisation. 
• Acceptability of sputum is determined with a Gram stained smear (pus cells >25/LPF, epithelial cells <10/HPF) 
and only representative samples are accepted.
• 24-hour sputum collections are not acceptable.
Tracheal Aspirate
• Tracheal aspirates are collected through an endotracheal tube and are subject to the same limitations as 
sputum specimens.
Non-Directed Bronchoalveolar Lavage
• This method provides a lower respiratory tract sample without the need for bronchoscopy. 
• A trained physician passes a suction catheter down the endotracheal tube until resistance is met. 
• Inject an aliquot of sterile saline and then aspirate at least 1 ml of secretions.
• Non-directed techniques have been found to give results comparable to bronchoscopic methods.
Dermatological Specimens
Skin Scrapings
• Clean skin with 70% alcohol.
• Scrape edges of lesion (as edge has greatest amount of viable fungus) with a blunt scalpel blade.
• Collect skin scales in a sterile petri dish or similar wide-mouthed container or alternatively, skin scrapings may 
be collected in a clean, dry piece of paper folded securely with Scotch tape and labelled properly.
• If a skin scraping does not yield sufficient material, then a swab or Scotch tape could be pressed on the lesion.
Nail
• Clean nail with 70% alcohol. 
• Examine for damaged, discoloured, brittle or dystrophic area. 
• Material should be taken from the affected areas. 
• Entire thickness of the damaged nail should be cut as far back as possible. Any crumbly material or material 
under the nail should be collected and sent in a sterile container.
• If skin lesions are present they should be scraped and the material collected should be sent separately.
Hair and Scalp
• A Wood’s light, if available, may be helpful in selecting specimens. 
• Pluck broken or lustreless hairs from periphery of lesion. Scrape scalp from edge of hair loss area.
• Do not cut hair.
• If hair are broken off (endothrix), it often may be necessary to scrape the coiled hair stubble from the scalp with 
a sterile blade or slide edge, rather than plucking with tweezers. 
• In piedra infections, cut infected hair with scissors. 
• Submit specimen to laboratory in sterile petri dish.
Specimen Processing and Microscopy
• Ensure that at the time of receipt of sample, documentation is complete, including provision of relevant history 
for interpretation of results.
• Determine acceptability and adequacy of specimen. 
• If specimen collection did not comply with protocol or sample is inadequate for multiple tests to be 
performed simultaneously, immediately inform referring physician.
• Prioritise performing sensitivity and culture to other tests, except for nails and skin scrapings from suspected 
tinea versicolor.
• Visually inspect the specimen to observe necrosis, purulence and grains. 
• To improve sensitivity, use most purulent, necrotic and blackened portion of specimen for smear preparation 
and culture inoculation.
• Inoculate swab specimens directly on the surface of appropriate media.
• Issue reports of fungal smear on the presence and description of fungal elements the same day.
• Positive culture results of samples from CSF, sterile body fluids, tissues and other significant sites should be 
informed to clinicians as soon as possible.
Fig. 1.1 Fig. 1.2
Specimen Collection, Transport and Processing
Collecting skin scrapings from toe web. Transferring the collected material to a sterile petri dish.
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Box 1.1: Factors increasing diagnostic sensitivity
• Examination of a large amount of tissue or other materials
• Selection of necrotic, purulent or caseous material
• Use of optical brighteners
• Centrifugation
• Development of expertise
Table 1.1: Specimen processing requirements and appropriate microscopy techniques
Specimen type Specimen processing Direct microscopy techniques
Fluids
Blood culture • Incubate 2 bottles at 37°C in an automated 
system.
• Perform microscopy and subculture once 
positive.
• Gram stain
• 10% KOH wet mount
• India ink
• PAF stain (for gram 
positive branching 
rods such as Nocardia, 
Actinomyces etc.)
CSF and other sterile body 
fluids
• Centrifuge CSF in sterile tube at 2000-2500 
rpm for 10 minutes.
• Pour the supernatant back into the collection 
container and store for antigen detection. 
• The pellet is used for smear and wet mount 
and for subsequent culture.
• Gram stain
• 10% KOH wet mount
• India ink
• PAF stain
Tissue and Swabs
Biopsy • Mince using a sterile blade after placing 
tissue in a sterile petri plate (grinding will 
inhibit growth of mucoraceous molds).
• Inoculate tissue on culture plates.
• Gram stain
• 10% KOH wet mount
• India ink
• PAF stain
• Calcofluor white stain
Swabs •	 Directly inoculate onto media.
•	 If there is insufficient material, a small 
amount of normal saline can be added to re-
suspend material. 
•	 If granules are visualised, wash, centrifuge 
and crush for processing.
• Gram stain
• 10% KOH wet mount
• India ink
• PAF stain
• Calcofluor white stain
Respiratory tract secretions
Sputum and tracheal aspirates
 
• Mix equal volume of sputasol and vortex till 
specimen is liquefied. 
• Centrifuge at 1200 g for 10 minutes.
• Discard supernatant and re-suspend 
centrifuged deposit. 
• Use 1 drop of sediment for microscopy and 
media inoculation.
• Alternatively, directly inoculate on culture 
media, without pre-treatment.
• Gram stain
• 10% KOH wet mount
• India ink
• PAF stain
• Calcofluor white stain
Bronchoalveolar lavage, 
bronchoscopy aspirates/
washings
•	 Centrifuge at 1200 g for 10 minutes.
•	 Discard supernatant and re-suspend 
centrifuged deposit. 
•	 Use 1 drop of sediment for microscopy and 
media inoculation.
• Gram stain
• 10% KOH wet mount
• India ink
• PAF stain
• Calcofluor white stain
Dermatological specimens
Skin scrapings • Placed directly on the agar surface using 
sterile forceps. 
• Press lightly in to agar surface.
• 10% KOH wet mount
• Calcofluor white stain
Nail • Cut into small pieces with the scalpel or 
sterile blade.
• Place directly on the agar surface using 
sterile forceps. 
• Press lightly in to agar surface.
•	 10% KOH wet mount
•	 Calcofluor white stain
Hair and scalp
 
• Cut strands of hair into 1 mm lengths with a 
scalpel or sterile blade. 
• Press lightly into selective media with sterile 
forceps.
• 10% KOH wet mount
• Calcofluor white stain
Table 1.2: Stains for microscopic examination of clinical material
Principle Procedure Controls
Gram stain
Stains walls containing protein-
sugar complexes called 
peptidoglycan. Typically have 
low lipid content. Gram positive 
fungi stain violet. Gram negative 
fungi decolourise and stain pink 
with safranin.
• Heat-fix the smear.
• Apply crystal violet stain to the smear for 30 
seconds. Drain stain and wash with water.
• Add Gram’s Iodine for 30 seconds and the 
drain excess.
• Decolourise with 95% ethyl alcohol.
• Counterstain with safranin for 30 seconds 
and then drain excess.
• Rinse and allow to air dry.
• Examine under microscope.
• Positive control: 
Staphylococcus aureus
• Negative control: 
Escherichia coli
10% potassium hydroxide (KOH) wet mount
Dissolves keratin and 
proteinaceous components of 
tissue. Makes fungal elements 
prominent.
• Place specimen on slide.
• Add a drop of 10% KOH.
• Apply coverslip and gently warm the slide 
over a flame or warmer. Alternatively leave 
the slide at room temperature for 10 minutes.
• Gently press the coverslip to spread the 
already softened tissue evenly on the slide.
• Examine under a microscope.
Control: Aspergillus spp.
Specimen Collection, Transport and Processing
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Calcofluor white stain
Binds to chitin and cellulose 
in fungal cell wall. Better 
visualisation of fungal elements 
than 10% KOH. Fungal 
elements appear bright apple 
green.
• Prepare a smear from specimen.
• Add 1 drop of Calcofluor white stain.
• Add 1 drop of 10% KOH for thick specimens, 
cutaneous specimens and tissue.
• Apply coverslip and allow the slide to remain 
at room temperature for 5 minutes.
• Examine slide under fluorescent microscope 
using manufacturer’s recommendation for 
wavelength and filter.
• Positive control: 
Aspergillus spp.
• Negative control: E. coli
India ink
Negative staining method. Used 
to detect encapsulated strains 
of Cryptococcus.
This stain could also be 
performed with suspected 
Cryptococcus colonies. Small 
portion of isolated colony 
should be emulsified in India 
ink.
Some strains of C. neoformans, 
as well as other Cryptococci 
may not produce discernible 
capsules in vitro.
• Place a small drop of India ink on a slide.
• Fluid and CSF should be centrifuged and a 
small amount of this should be mixed with 
India ink.
• In thick specimens like pus and sputum 
a drop of 10% KOH along with India ink 
improves visualisation.
• Leukocytes, fat droplets, and tissue 
cells may look like C. neoformans cells. 
Leukocytes and tissue cells can be dissolved 
by adding a drop of 10% KOH.
• Positive control: C. 
neoformans 
• Negative control: C. 
albicans
Acid-fast stain (Ziehl-Neelsen stain)
Mycolic acid is a waxy lipid that 
makes cell walls highly durable. 
Acid-fast walls only stain with 
carbol-fuschin stain after 
being heat-treated and do not 
decolourise with acid-alcohol 
solvent.
Acid-fast organisms stain 
pink. Non-acid fast organisms 
stain blue. Partially acid-fast 
organisms stain pink to purple.
• Prepare heat-fixed fungal smear.
• Stain with carbol fuchsin.
• Heat stain until vapour just begins to rise 
(60°C).
• Allow the heated stain to remain on the slide 
for 5 minutes. Wash stain with distilled water.
• Cover the smear with 3% acid alcohol for 
5 minutes or until the smear is sufficiently 
decolourised. Wash with distilled water.
• Cover the smear with malachite green stain 
for 1-2 minutes, using longer time when the 
smear is thin. Wash off stain with distilled 
water.
• Allow to air dry.
• Examine the smear under a microscope.
• Positive control: M. 
tuberculosis
• Negative control: E. coli
Lactophenol cotton blue 
Used for visualisation of fungal 
elements and structures. Mainly 
performed from fungal colonies 
and used for identification. 
In case of non-availability of 
Calcofluor white stain, this can 
also be used for microscopic 
examination of clinical 
specimens.
• Place 1 drop of LPCB on slide.
• Immerse fungal colonies with help of Scotch 
tape or tease mount.
• Apply coverslip.
• Visualise under microscope.
• Controls: A. niger, T. 
mentagrophytes
 
FUNGAL MEDIA AND 
CULTURES
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Fungal Media and Cultures
Mohammad Zeeshan and Seema Irfan
Once the specimen has been recieved, the next step is preparation of slides for microscopic examination and 
inoculation of appropriate culture media. There are a few principles that must always be kept in mind: always 
inoculate the enriched media first with the clinical specimen followed by inoculation of selective media; 2 sets of 
media should be inoculated, with 1 set incubated at 25-30°C and a duplicate set at 35 ± 2°C. 
Table 2.1: Types of media
Enriched media Supports rapid growth of pathogenic and non-
pathogenic fungi.
• SBA
Selective media Contains chemicals and antibiotics that only allow 
the growth of certain fungi and inhibit the growth of 
saprophytic molds and bacteria respectively.
• SDA
• Chromogenic BiGGY agar
• Mycosel
Differential media Differentiates between closely related fungal species. • Chromogenic BiGGY agar
• CHROMagar
• DTM
Media for sporulation Induces sporulation and helps in identification. • CMT 
• PDA
• Water agar
Fungal Media
The yield of most fungi is improved by direct culture of samples on fungal media. Cultures may be negative 
on bacterial media for some fungi, such as Histoplasma, Mucorales and Coccidioides spp. Similarly, culture of 
Aspergillus spp. on bacterial media is 30% less effective than on fungal media. Common fungal media and tests 
used are:
• Sabouraud’s dextrose agar
• Mycobiotic or Mycosel agar
• Cornmeal Tween-80 agar
• Chromogenic BiGGY agar
• Dermatophyte test medium
• Water agar
• Christensen’s urea agar (urease test)
• Germ tube test 
Sabouraud’s Dextrose Agar (With or Without Antibiotic)
Sabouraud’s dextrose agar (SDA) is a universal primary medium for fungal culture. The original version of the agar 
was composed by Sabouraud’s to isolate dermatophytes from non-sterile specimens, and was a low pH (5.6) 
medium with high dextrose content (4%), casein and animal peptic digest.  The Emmons modification decreased 
dextrose to 2% and made the pH neutral (6.9-7.0). Other modifications since have included addition of various 
antibiotics and antifungals to change its selectivity and make it suitable for a variety of specimens.
Procedure
• Pour the clear slightly amber tinged medium into tubes as a slant or on petri plates.
• Inoculate tissue and fungal isolates by stabbing into the medium. 
• Streak fluid specimens such as pus, aspirates, yeast isolates and yeast-like fungi in to quadrants.
• For plates inoculated directly from specimen, incubate at 25 ºC, 30 ºC and 37 ºC.
• For temperature tolerance studies, incubate at an even wider range of temperatures (15-55 ºC).
• Since SDA is a primary fungal culture medium, duration of incubation may be several weeks.
Interpretation
• Description of the colony’s forward and reverse surface and any diffusible pigment into the medium should be 
noted.
Limitations
• Addition of selective substances may not allow certain fungi to grow easily. On the other hand, SDA without 
antibiotic may not inhibit highly resilient bacteria in the specimen, making isolation of fungi a challenge.
Quality Control
• Positive control: growth of C. albicans and T. mentagrophytes 
• Negative control: no growth of E.coli
Mycobiotic or Mycosel Agar
Mycobiotic or Mycosel selective medium principally formulated for the isolation of dermatophytes but also used 
for the isolation of other pathogenic fungi from specimens contaminated with saprophytic fungi and bacteria. The 
medium consists primarily of peptones from a pancreatic digest of soybean meal and dextrose. The selective 
agents are cycloheximide and chloramphenicol. Cycloheximide inhibits the faster-growing saprophytic fungi. 
Chloramphenicol inhibits Gram-negative and Gram-positive organisms. Susceptibility to cycloheximide may be 
used for identification of fungi.
Procedure
• Direct inoculation from specimen
• Inoculate and streak the specimen as soon as possible after it is received in the laboratory. 
• Incubate the plates at 25-30 °C in an inverted position with increased humidity for 30 days or longer in an 
aerobic atmosphere. 
• Examine media for fungal colonies exhibiting typical colour and morphology.
• Cycloheximide susceptibility test
• Make a suspension of pure colony of Candida species in distilled water (about 1.0 McFarland turbidity).
• Streak a loop full suspension on the agar plate in the following sequence to avoid transfer of cycloheximide 
to control plate.
• SDA
• Mycobiotic or Mycosel agar
• Incubate at room temperature for 3 days.
• Observe both cultures for growth and record as equal to (=) or inhibited (-) or growth on Mycosel (+).
Interpretation
• Direct inoculation from specimen
• Positive: growth on plate.
• Negative: no growth on plate. 
• Cycloheximide susceptibility test
• Positive: growth on Mycosel equal to growth on SDA.
• Negative: no growth on the Mycosel plate or less growth on Mycosel agar than on SDA. 
• NOTE: the test should not be read after 3 days as sensitive strains may begin to grow on Mycosel agar, and 
false positive result may be seen.
Limitations
• Cycloheximide in the plate is also inhibitory to some clinically relevant species. These include some Candida 
species, A. fumigatus, mucoraceous fungi, and C. neoformans.
Quality Control
• For growth
• C. albicans good growth.
• Staphylococcus aureus complete inhibition.
• Cycloheximide susceptibility test
• Positive control: T. mentagrophytes and C. albicans.
• Negative control: A. niger.
Fungal Media and Cultures
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Cornmeal Tween-80 Agar
CMT agar is a well-established medium used for cultivation of fungi as well as to study chlamydospores 
production by Candida species and other yeasts.
Procedure
• Pick a single colony of yeast from plate using a sterile straight wire.
• Make three parallel cuts ¼ inch or 1 cm apart on the surface of the agar, holding the inoculating wire at 
approximately 45° angle.
• Using sterile forceps, place a coverslip over the cross. Reduced oxygen tension stimulates chlamydospore 
production. 
• Invert plate and incubate up to 2-3 days (96 hours) at 25 ± 2°C. 
Interpretation  
• Using low power objective of microscope, scan the growth on CMT agar.
• Determine at the outset if pseudohyphae are present. The observation of pseudohyphae and blastoconidia put 
an unknown isolate into the genus Candida. 
• Examine plates daily for the development of chlamydospores. 
Limitations 
• None of the cornmeal agar patterns are diagnostic with the exception of chlamydospore production by   
C. albicans.
• Subculture where necessary and perform appropriate biochemical tests for further identification. 
Quality Control
• Set up known controls.
• C. albicans: good growth, white colonies and chlamydospores production.
• C. krusei: good growth, white to cream colonies but no chlamydospores production.
Chromogenic Bismuth Glycine Glucose Yeast (BiGGY) Agar 
BiGGY agar is a partially selective and differential medium for the cultivation and identification of Candida species 
from pure cultures or clinical specimens. Candida species, through a process of substrate reduction, reduces the 
bismuth salt to bismuth and sulfite to sulfide. Bismuth and sulfide combine to form a brownish to black precipitate 
that stains colonies and may diffuse into the medium. Also bismuth and sulfur compounds are inhibitory to many 
bacteria. Yeast extract and glucose provide essential nutrients for growth. Glycine is an additional nutrient, but 
also inhibits many bacterial species at the high concentration used in this medium. 
Procedure:
• Inoculate specimen on media as soon as it is submitted using streak plate technique when isolating pure 
cultures from specimens containing mixed flora. 
• If culture is drawn from swab, then roll swab over a small area of the surface at the edge and then streak from 
this inoculated area. Streak in all four corners.
• Invert plate and incubate at 35 ± 2°C aerobically for 24-48 hours and observe daily for 5 days.
Interpretation
• C. albicans: smooth, round brown-black colonies with mycelial fringe without sheen or any diffusible pigment 
into surrounding media.
• C. tropicalis: smooth, dark brown to black colonies with a metallic sheen.
• C. krusei: large, flat, shiny, wrinkled brown-black colonies with yellow diffusible pigment.
Limitations
• Further testing should be performed on colonies from pure culture for complete identification.
• Some bacteria may grow on the agar but can be differentiated from yeast using microscopy. 
Quality Control
• C. albicans, C. krusei, C. tropicalis: characteristic colonies.
• E. coli: complete or partial growth inhibition. 
Dermatophyte Test Medium
Dermatophyte test medium is used as a screening medium for the recovery, selection and differentiation of 
dermatophytes (Microsporum, Trichophyton and Epidermophyton) from keratinous specimens (hair, skin and nails). 
Nitrogenous and carbonaceous compounds are provided by soy peptone. Cycloheximide inhibits saprophytic 
molds while chloramphenicol and gentamicin inhibits Gram-negative and positive bacteria. The medium is yellow 
and turns red with growth of dermatophytes due to the presence of phenol red indicator. 
Procedure
• Skin scraping
• Place the specimen directly on the agar surface using sterile forceps. It should be pressed into the agar 
slightly.
• Nail
• Cut into small piece with the scalpel or sterile blade placed directly on the agar surface using sterile forceps. 
It should be pressed into the agar slightly. 
• Incubate plate at 25°C for 2 weeks. 
• Examine plate daily for the presence of growth and pigment.
Interpretation
• Positive: growth and red pigment production.
• Negative: no growth.
Limitations
• Prolonged incubation may cause deterioration on antibiotics in the media and therefore cause the overgrowth 
of saprophytic molds.   
Quality Control
• Positive control
• T. mentagrophytes fair to good growth, alkaline (red pigment). 
• Negative control
• P. aeroginosa partial to complete inhibition. 
• A. niger partial to complete inhibition.
Fungal Media and Cultures
Water Agar
Water agar is a nutritionally-deficient media known to enhance production of spores and conidia of sporulation.
Media Preparation
• Mix 20 grams of agar in 1 litre of distilled water.
• Bring reagents to a boil. 
• Autoclave at 15 lb/in2 for 15 minutes.
• Cool in slanted position or store as butts to be melted down and used as slants or plates as needed.
Procedure
• Using a sterile loop, pick a small sample from colony margin.
• Emulsify the colony in sterile normal saline.
• Transfer a drop from normal saline to water agar plate. Do not streak and allow the drop to be absorbed in the 
media.
• Wrap a paraffin film around the sides of the plate to cover the opening (or use masking tape to hold the lid 
down).
• Incubate the water agar plate at room temperature.
Interpretation
• As the colony grows, observe sporulation with LPCB preparation. 
Limitations
• In case of infection due to more than one agent, the strain that grows in a more limited manner may pass 
unnoticed for a long period. Therefore streak on fresh selective culture plates to identify individual colonies. 
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Quality Control
• Cultural Response: cultural characteristics observed after 48-72 hours incubation at 25-30°C. 
• C. albicans: fair to good growth.
• Saccharomyces cerevisiae: fair to good growth.
Interpretation
• Positive test: A germ tube emerges laterally from a yeast cell, without constriction at the point of origin, e.g. C. 
albicans and C. dubliniensis (Fig 2.1).
• Negative test: If there are yeast cells only or extension from a yeast cell with constriction at the point of origin, 
e.g. C. tropicalis, C. glabrata and other yeasts (Fig 2.2).
                             
Limitations
• Early pseudohyphae formation as seen in C. tropicalis may be falsely interpreted as germ tube formation.
• This test is only for preliminary identification and requires definitive identification.
Quality Control
• C. albicans: positive control.
• C. tropicalis: negative control.
Fungal Media and Cultures
Fig. 2.1 Fig. 2.2
Christensen’s Urea Agar (Urease Test)
Urea agar is used for the differentiation of the yeast-like fungi and also in the identification of aerobic 
Actinomycetes and Trichophyton species. Breakdown of urea by urease producing fungi release ammonia, with 
increase in pH leading to colour change of medium from yellow (pH 6.8) to red (pH 8.1). 
Procedure
• Inoculate the urea agar slope with heavy amount of pure culture.
• Observe at 24 to 48 hours for yeast and 1 week for dermatophytes.
Interpretation
• Positive: urea positive organism produces alkaline reaction indicated by pink colour.
• Negative: no colour change.
Limitations
• Bacterial contamination may cause false positive reaction. 
Quality Control
• Positive control: C. neoformans. 
• Negative control: C. albicans.
Germ Tube Test
Germ tube test is used for differentiation of C. albicans from other Candia species. Approximately 95-97% of C. 
albicans develop germ tubes when incubated in serum.
Procedure
• Pick a small sample from yeast colony and gently emulsify with 3-4 drops of serum in a small glass tube. (Note: 
a large colony sample inhibits germ tube formation.)
• Incubate the tube at 37°C for 2 hours. Be careful as increasing the period of incubation leads to false positive 
results. 
• Transfer a drop of serum onto a slide for examination.
• Place a coverslip and examine slide under microscope at low (x10) and high power (x40) objectives.
Fungal Culture: Selection, Preparation and Reading
• For isolation of fungi from potentially contaminated specimens, simultaneously inoculate a nonselective 
medium and a selective medium.
• Sort and place new cultures slip in numerical order. Separate according to reading schedule and length of 
incubation. Prolonged incubation may cause drying of media, therefore secure with paper tape around the 
whole circumference of the plate.
• Examine cultures daily to observe the rate of growth, gross colony morphology and physical changes or 
contamination in media.
• Once fungal culture plates have been examined, place them in appropriate stacks and re-incubate. 
• Remove any culture medium showing fungal growth for further work-up.
• Correlate with culture sample submitted in the bacteriology section of laboratory. 
• Note any contamination and record on the slip.
• A senior mycology technologist/consultant should also review the growth for interpretation. 
• Cerebrospinal fluid, blood, samples from sterile sites and special request specimen cultures should be read 
daily for the first 2 weeks and 2 times a week for the next 2 weeks. 
• Positive specimens are worked up immediately. 
• Any bacterial growth in these samples should also be shown to a senior mycology technologist/consultant 
for appropriate action.
• Routine screening of all other fungal cultures should be done daily for the first week and 2 times a week for the 
remaining incubation period. 
• Any mold referred from the bacteriology section is processed and worked up the same day. 
• All final cultures should be reviewed and signed by a senior mycology technologist/consultant.
Table 2.2: Types of fungal media and properties
Type of media Properties pH Incubation Comments
Sheep blood agar General purpose 
enrichment media 
7.4 ± 0.2 37°C 
aerobically
Sabouraud’s 
dextrose agar 
without antibiotic
General purpose
enrichment media
5.6 ± 0.2 37°C and 28°C 
aerobically 
• Low pH and high dextrose content 
enhance fungal growth and inhibit 
bacterial growth.
• Incubate at different temperatures in 
order to observe the rate of growth.
• Dextrose is used as a source of 
energy.
Sabouraud’s 
dextrose agar with 
chloramphenicol 
Enrichment media
Selective (0.5% 
chloramphenicol) 
5.6 ± 0.2 25-30°C 
aerobically
• With the addition of antibiotic 
becomes more selective and 
helps in isolation of yeasts, molds, 
dermatophytes and Nocardia.
Germ tube test positive: true 
hyphae arising from yeast cell.
Germ tube test negative: pseudohyphae 
arising from yeast cells.
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Mycobiotic or 
Mycosel agar
Enrichment media
Selective 
(chloramphenicol & 
cyclohexamide)
6.9 ± 0.2 25-30°C 
aerobically
• Cyclohexamide inhibits the faster-
growing saprophytic fungi but is also 
inhibitory to some clinically-relevant 
species include some Candida and 
Aspergillus species, mucoraceous 
fungi and C. neoformans. 
• Chloramphenicol inhibits Gram-
negative and Gram-positive 
organisms.
• Reading after 72 hours is not reliable.
Potato dextrose 
agar
General purpose
sporulation medium
Selective (tartaric 
10%)
3.5 ± 0.1 25-30°C 
aerobically
• Very low pH with tartaric acid inhibits 
bacterial growth.
• Stimulates conidium production in 
fungi.
• Stimulates pigmentation production 
in some dermatophytes.
CMT agar General purpose 
and sporulation 
medium
6.0 ± 0.2 25-30°C 
aerobically
• Tween-80 is incorporated for the 
demonstration of pseudohyphae, 
chlamydospore and arthrospore 
formation.
• Chlamydospore production is best 
obtained if the yeast inoculum is 
placed under a coverslip or following 
subsurface inoculation creating a 
microaerophilic environment.
Dermatophyte test 
medium
Selective 
(chloramphenicol & 
cyclohexamide)
Differential 
5.5 ± 0.2 25-30°C 
aerobically
• Cyclohexamide inhibits saprophytic 
molds, chloramphenicol inhibits 
bacteria.
• The morphology and microscopic 
characteristics are easily identified 
with this medium.
• Presence of phenol red indicator.
• The medium is yellow and turns red 
with growth of dermatophytes.
Bismuth glycine 
glucose yeast agar 
Selective 
Differential 
6.8 ± 0.2 37°C 
aerobically
48-72 hours
• Final identification with biochemical 
and morphological tests needed.
CHROMagar Selective 
Differential
5.9 ± 0.2 35 ± 2°C 
aerobically 24-
48 hours
• Examine plate for amount of growth 
and colour formation.
• Isolation and presumptive 
identification of yeast and filamentous 
fungi.
• Differentiation of C. albicans, C. 
tropicalis and C. krusei.
• Due to the differences in morphology 
and colours of the yeast colonies, this 
medium facilitates the detection of 
mixed yeast cultures in specimens.
Christensen’s urea 
agar
Identification  6.7 ± 0.2 25-30°C 
aerobically
• The ability to hydrolyse urea is an 
important phenotypic characteristic 
for the presumptive identification of 
•  Cryptococcus, Trichosporon and 
Rhodotorula spp.
• Differentiates between T. 
mentagrophytes and T. rubrum.
• The medium contains 2% urea with 
phenol red serving as the indicator.
Table 2.3: Specimen-specific requirements for culture, media and reading frequency
Standard media inoculated Aerobic incubation Reading of culture Target organism and fungal 
element
Temperature Report
All tissue samples and body fluids (except CSF)
2 SDAC
1 Mycosel
1 PDA
1 SBA
1 CHROMagar/BiGGY
1 SDAC, SBA, 
CHROMagar/
BiGGY  at 35-37oC
1 SDAC, PDA, 
Mycosel at 22-
26oC
4 weeks 
Usually isolates 
appear in 48-96 
hours; some 
organisms may 
take longer.
Daily for first week, 
then twice weekly 
for the next 3-4 
weeks.
• Yeast
• Filamentous fungi
• Dimorphic fungi
CSF
2 SDAC
1 SBA
1 CHROMagar/BiGGY if 
smear positive for yeast
1 SDAC, SBA, 
CHROMagar/
BiGGY at 35-37oC
1 SDAC at 22-
26oC
4 weeks
Usually isolates 
appear in 48-96 
hours.
Daily for the first 2 
weeks, then twice 
weekly for the next 
3-4 weeks.
• Cryptococcus
• Candida
• Aerobic 
actinomycetes
• Filamentous molds
Respiratory tract secretions
2 SDAC
1 Mycosel
1 PDA
1 SBA
1 SDAC, SBA at 
35-37oC
1 SDAC, PDA, 
Mycosel at 22-
26oC
4 weeks
Usually isolates 
appear in 48-96 
hours.
Daily for the first 
weeks , then twice 
weekly for the next 
3-4 weeks.
• Yeast
• Filamentous fungi
• Dimorphic fungi
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Blood and bone marrow culture
Blood culture bottles 
containing brain heart 
infusion (BHI) broth
Subculture on SDA, 
SBA, Mycosel and 
CHROMagar/BiGGY if 
smear positive for yeast
On SBA only if smear 
negative
35-37oC Keep in Bactec 
automated 
system for 4 
weeks.
If no growth 
after 7 days, 
subculture on 
SBA every week 
for the next 3-4 
weeks.
Keep subculture 
for 72 hours.
Daily for the first 
weeks, then twice 
weekly for the next 
3-4 weeks.
• Yeast
• Filamentous fungi
• Dimorphic fungi
Dermatological specimens
1 DTM
2 SDAC
1 Mycosel
1 SDAC at 35-
37oC
1 SDAC, DTM, 
Mycosel at 22-
26oC
4 weeks
Usually colonies 
appear in 7-10 
days.
Daily for first week, 
then twice weekly 
for the next 3 
weeks.
• Dermatophytes
• Yeasts
• Saprophytes as 
superimposed 
infective agents
Fungal Media and Cultures
Table 2.4: Daily routine of mycology lab
Step 1: Quality Control
• Lab equipment
• Media and strains
• Light exposure
• Temperature regulation
Step 2: Fungal Smears
• Preparation
• Reading schedule – 3 times a day
• Review by senior technologist/consultant
Step 3: Fungal Cultures
• Preparation
• Reading schedule – daily, weekly and monthly
• Cross-checking growth with bacterial culture sample
• Review by senior technologist/consultant
Step 4: Fungal Slide Mounts
• Preparation
• Reading
Microscopic Examination of Culture
An essential feature of fungal identification is the microscopic morphology of the isolate. The common techniques 
used for observing fungal culture under the microscope are given below.
Tease Mount Preparation
• Place a clean glass slide on the work bench and put a small drop of LPCB solution in the middle of the slide.
• Remove a fragment of a fungal colony (approximately 1-2 mm from the periphery) with a wooden stick and 
place on the LPCB solution.
• Gently tease the fragment with two wooden sticks until it has been separated.
• Gently place a coverslip over it. Do not tap or push down as this may dislodge conidia from conidiophores.
• Carefully examine the slide under low (x10) and high power (x40) objectives of the microscope for the 
characteristic shape and arrangement of the spores, hyphae, budding yeasts etc. 
• For a permanent preparation, rim the coverslip with clear nail polish or Permount.
Fungal Slide Mount (Fig. 2.3)
Best technique for visualization of fungal structures without disruption of arrangement.
• Take a sterile petri dish and cover it with tissue paper. Place a bent sterile glass tube or two sterile wooden 
sticks on the tissue paper.
• Place a sterile slide on the wooden sticks/glass tube so that it is raised above the level of the tissue paper.
• Cut a block (1x1 cm) of PDA and place it in the middle of the slide. Inoculate by stabbing all 4 sides of the 
block with the fungus that needs to be identified. Place a sterile coverslip on top of the block.
• Soak the tissue paper with sterile distilled water.
• Observe daily for growth and sporulation and keep the tissue soaked to ensure the environment remains moist.
• When sporulation is complete, remove coverslip from the surface of the media block, place a drop of LPCB on 
a fresh slide and place this coverslip on it. 
• Discard the block of media from the slide, put a drop of LPCB on it and place a coverslip on top.
• Examine both slides for sporulation and arrangement of microscopic structures to identify the fungus
Adhesive/Scotch Tape Preparation
• Place a clean glass slide on a sheet of white paper.
• Place a small drop of LPCB in the center of the slide.
• Touch the adhesive side of a small length of transparent tape to the surface of the colony.
• Adhere the length of the tape to the surface of the slide with LPCB.
• Observe under microscope for characteristic  shape and arrangement of spores and other fungal elements.
Fig. 2.3: Slide culture technique.
Reading of Smear
• All smears must be read within 24 hours of preparation, at least 3 times a day: morning, noon and afternoon. 
• Positive smears should be rechecked by a senior mycology technologist or consultant. 
• Negative samples from sterile sites should be reviewed by a senior mycology technologist or consultant. 
• For tissues with high clinical suspicion of fungal infection, prepare more than one smear especially from 
relatively necrotic portion before labeling it negative.
Quality Control
The following measures should be taken on a daily basis to ensure QC:
• Check and record temperature readings of all incubators, refrigerators and freezers every morning. 
• Log and report abnormal readings to the in-charge technologist. 
• Review QC of media and strains, and record results. In case of incorrect results, take corrective action.
• Before use, physical check of plates is necessary for any signs of deterioration and contamination.
• Maintain proper inoculation conditions, temperature and pH for optimal fungal growth. Excessive heating and 
inappropriate pH may cause delayed growth or growth inhibition.
• Prevent prepared media from unnecessary light exposure.
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Diagnosis of Fungal Infections: Clinical Lesions, 
Microscopic Examination and Culture
This chapter describes common clinical presentations, growth factors, and gross culture and microscopic 
appearance of fungi prevalent in Pakistan. Traditionally, fungal infections were diagnosed when they manifested 
as superficial cutaneous infections. However, in the past few decades, a significant number of invasive infections 
due to haematological dissemination of fungal diseases have been diagnosed. This increase in incidence is 
attributable to immuncompromised states (for instance, patients suffering from haematological malignancies, 
undergoing chemotherapy, uncontrolled diabetes, infectious diseases such as HIV/AIDS) as well as improvements 
in diagnostic techniques and shortened turnaround times. Currently, antimycotics are available to manage 
fungal diseases but inherent resistance to antifungal therapy remains a problem for some species involved in 
disseminated infections.
Box 3.1: Definitions
Mold (mycelial form) 
Fungus that grows in the form of multicellular filaments called hyphae.
Yeast
Fungus that grows as a single cell. 
Dimorphic Fungi
Fungus can exist as in both yeast and mold (mycelial) forms. Can be cultured in enriched media at 25-30ºC to 
yield mold and at 35-37ºC to yield yeast form, e.g. Sporothrix schenckii.
Table 3.1: Notable identification features
• Location: intracellular or extracellular
• Capsule: non-capsulated or encapsulated (e.g. Cryptococcus 
on India ink smear)
• Septa: aseptate or septate
• Septa: thin or wide
• Hyphae: present, absent or pseudohyphae
• Hyphae: hyaline or pigmented
• Hyphae: acute- or wide-angled branches 
• Budding: multiple or unicellular yeasts
• Budding: narrow or broad-based yeasts
• Filaments: non-branching or branching (e.g. Actinomycetes 
or Nocardia)
• Rods: non-branching or branching (e.g. Nocardia)
• Arthroconidia
• Chlamydoconidia 
• Endothrix 
• Spherules 
• Endospores 
• Sclerotic bodies 
Candida
Joveria Farooqi and Kauser Jabeen
Candida is a commensal of skin, oral and intestinal flora in humans, and disease generally results when immunity 
is lowered (e.g. antibiotics use, stress, diabetes) or completely compromised (e.g. HIV/AIDS). Infection can result 
in a spectrum of clinical presentations and some species are known to have a predilection for certain sites: C. 
albicans is the most common cause of oral and vulvovaginal candidiasis; C. parapsilosis is frequently reported in 
nail-related infections; and C. parapsilosis and C. pelliculosa are strongly associated with nosocomial infections.
In recent years, the emergence of resistance has led to antifungal susceptibility testing and reporting in invasive 
specimens. C. glabrata and C. krusei are known for their resistance to fluconazole (the former acquired and the 
latter intrinsic).
Clinical Presentation
Table 3.2: Types of Candidiasis
Invasive Semi-invasive Non-invasive
• CNS candidiasis
• Candida endophthalmitis
• Candida endocarditis, pericarditis 
and endovasculitis
• Intra-abdominal candidiasis
• Candida pyelonephritis or urinary 
fungus ball
• Candida osteomyelitis and arthritis
• Candidemia
• Chronic disseminated candidiasis
• Esophagitis
• Chronic mucocutaneous 
candidiasis
• Oral thrush
• Otitis externa
• Cutaneous and onchomycosis
• Chronic mucocutaneous candidiasis
• Candiduria
• Vulvovaginitis
One of the commonest presentations of candidiasis. 
White exudate on oral mucosa due to candida 
overgrowth and mucocutaneous inflammation. Oral 
thrush is associated with extremes of ages, antibiotic 
therapy, chronically ill patients and is generally 
considered an early manifestation of disturbance in 
innate immunity.
Stain reveals abundant unicellular (budding yeasts) 
and multicellular (pseudohyphae) forms on squamous 
cells. Candida typically stains Gram positive. Genital 
thrush is associated with diabetes, pregnancy and 
compromised host immune status (recurrence 
common if inadequately treated). (x100)
Fig. 3.1.1-1 Oral thrush. 
Fig. 3.1.1-2 Genital thrush (vulvovaginitis), Gram 
stain of vaginal swab.
Oral thrush
Genital thrush (vulvovaginitis), Gram stain of 
vaginal swabFig. 3.1.1-1 Fig. 3.1.1-2 
Diagnosis of Fungal Infections (Clinical Lesions, Microscopic Examination and Culture)
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Characterised by patches of pseudomembranous  
white slough along the esophageal mucosa that 
can be easily wiped. Frequently accompanied by 
oral thrush. Candida esophagitis is mostly seen in 
immunocompromised patients. Classic symptoms 
include dysphagia, odynophagia and weight loss  
due to difficulty swallowing.
Culture of external auditory canal swab on blood agar 
showing white yeast colonies. However, interpret ear 
swab cultures cautiously as Candida is a known skin 
coloniser as well as an agent of otomycosis.
Fig. 3.1.1-7 Candida esophagitis. 
Fig. 3.1.1-8 Candida otomycosis, culture on SDA.
Itchy and at times malodorous rash typically between  
fourth and fifth toes due to Candida or dermatophyte  
infection. Often a feature of tinea pedis (athlete’s foot).
Recurrent candidiasis. Despite repeated antifungal 
therapy, the patient’s nails remained discoloured and 
pitted after 1 year. There is no evidence of invasive 
disease.
Fig. 3.1.1-5 Intertrigo. 
Fig. 3.1.1-6 Chronic mucocutaneous candidiasis. 
Pulmonary valve vegetation shows numerous budding yeast cells invading valve tissue. Yeast cells measure 6-8 
µm in diameter. (x100)
Fig. 3.1.1-9 Candida endocarditis, Gram stain.
Candida esophagitis
Candida endocarditis, Gram stain
Intertrigo
Candida otomycosis, culture on SBA
Chronic candidiasis
Fig. 3.1.1-7 
Fig. 3.1.1-9 
Fig. 3.1.1-5 
Fig. 3.1.1-8
Fig. 3.1.1-6
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Thickened and discoloured nail plate with subungual 
hyperkeratosis and onycholysis. White adherent plaque 
seen in intertriginous space of ring and little fingers.
Discoloured and pitted nails with a crumbling nail 
plate. Nail folds are swollen and inflamed and show 
marked subungual hyperkeratosis. 
Fig. 3.1.1-3 Onychomycosis. 
Fig. 3.1.1-4 Onychomycosis. 
Onychomycosis OnychomycosisFig. 3.1.1-3 Fig. 3.1.1-4 
C. albicans, 10% KOH smear C. albicans, Gram stain from blood culture bottleFig. 3.1.1-10 Fig. 3.1.1-11
Candida albicans
C. albicans is a dimorphic fungus that is a skin and gut commensal. Infection results in oral and vaginovaginal 
candidiasis in immuncompetent hosts, and fatal disseminated infections in immunocompromised patients. C. 
albicans is the most common fungal species isolated from clinical specimens. More recently, it has emerged as 
a cause of hospital-acquired infections, especially with implantable medical devices where it covers the surface 
with a biofilm. 
Oval to subspherical budding yeasts. Presence of 
abundant pseudohyphae in specimen suggests 
overgrowth and active infection. (x40)
Sometimes C. albicans can give the impression of 
spherical yeasts. The smear should be examined in 
several fields before deciding on the shape and 
morphology of the yeast cells. (x100)
Fig. 3.1.1-10 C. albicans, culture on 10% KOH.
Fig. 3.1.1-11 C. albicans, 10% KOH wet mount smear.
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Ovoid to subspherical budding yeast cells 6-8 µm in 
size. (x100) 
Confirmatory test to differentiate C. albicans from  
other Candida species. C. albicans produces tubular 
outgrowths (germ tubes or true hyphae) as opposed to 
elongation of a budding yeast (pseudohyphae). It is 
also seen in C. dubliniensis. (x40) 
Fig. 3.1.1-14 C. albicans, Gram stain.
Fig. 3.1.1-15 Germ tube test.On microscopy, pseudohyphae appear as long and 
slender tubules with clusters of round to oval 
blastoconidia (arrow). The presence of terminal double-
walled round chlamydospores is diagnostic of  
C. albicans. These chlamydospores may also be seen in 
C. dubliniensis but they are usually found in clusters and 
are more abundant as compared to C. albicans. (x40)
Most strains of C. albicans are susceptible to triazoles, 
echinocandins and amphotericin. However, due to 
emerging resistance, especially against triazoles and 
echinocandins, most labs perform antifungal 
susceptibilities. Clinical breakpoints for zone 
diameters (disc diffusion) and broth microdilution are 
now available in both EUCAST and CLSI References. 
Fig. 3.1.1-17 Susceptibility testing (disc 
diffusion, see chapter 4 for details). 
C. albicans, Gram stain
C. albicans, microsopy of CMT agar
Germ tube test
Susceptibility testing (disc diffusion, see 
chapter 4 for details)
Fig. 3.1.1-14
Fig. 3.1.1-16
Fig. 3.1.1-15
Fig. 3.1.1-17
Candida tropicalis
C. tropicalis is part of skin and gut flora and frequently results in disseminated invasive infections in neutropenic 
and cancer patients.
C. albicans, culture on SDA C. albicans, culture on chocolate agarFig. 3.1.1-12 Fig. 3.1.1-13
Cream coloured colonies. Small colony variants in 
overnight cultures give the impression of mixed growth.
Glistening creamy colonies sprouting mycelia or 
“fringes” – typical of C. albicans. These fringes may 
also rarely be seen in C. tropicalis colonies. Growth on 
chocolate agar shows even more prominent fringes or 
star-shaped colonies.
Fig. 3.1.1-13 C. albicans, culture on chocolate agar.
At 24-48 hours, small and large colony variants are  
seen. Smaller colonies are usually dome-shaped while 
the larger ones are dull white, dry and slightly elevated. 
Similar to chocolate agar, culture in blood agar has 
both small and large colony variants which become 
less prominent after 72 hours (3 days). The colonies 
are initially non-haemolytic, dry and elevated but turn 
dome-shaped after the third day.
Fig. 3.1.1-18 C. tropicalis, culture on chocolate agar.
Fig. 3.1.1-19 C. tropicalis, culture on SBA. 
C. tropicalis, culture on chocolate agar
C. tropicalis, culture on SDA
C. tropicalis, culture on SBA
C. tropicalis, culture on BiGGY agar
Fig. 3.1.1-18
Fig. 3.1.1-20
Fig. 3.1.1-19
Fig. 3.1.1-21
Day 4. Colonies do not glisten and are umbonated, with 
radial grooves around the edges only.
Colonies are dry, light to dark brown, with a silver 
metallic sheen, most prominent on the primary streak. 
They are also umbonated and have radial grooves 
around the edges.
Fig. 3.1.1-20 C. tropicalis, culture on SDA.
Fig. 3.1.1-21 C. tropicalis, culture on BiGGY agar.
C. tropicalis, Gram stain from 
positive blood culture bottle C. tropicalis, microsopy of CMT agar Fig. 3.1.1-23
Yeast size is around 4-6 µm, almost the same size as 
RBCs. Shape of cells is more oval than round. 
Pseudohyphae are frequently seen on smear made  
from clinical specimens. (x100)
Long slender pseudohyphae with elongated 
blastoconidia, arising successively from older 
blastoconidia. This gives the appearance of a rabbit 
head with long ears. (x40) Fig. 3.1.1-22 C. tropicalis, Gram stain from positive blood culture 
bottle. 
Fig. 3.1.1-23 C. tropicalis, culture on CMT agar.
Fig. 3.1.1-22
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Candida parapsilosis
C. parapsilosis is both a human commensal and an environmental pathogen, and is usually implicated in nail 
infections. It can result in a range of invasive diseases including endocarditis, endophthalmitis, meningitis and 
peritonitis.
Yeasts are oval and 4-6 µm in diameter, approximately 
the same size as red blood cells. Pseudohyphae are  
less common in clinical specimens. (x100)
Short slender delicate pseudohyphae with elongated 
blastoconidia, more tapered than C. tropicalis. Some 
swell up to form giant (balloon) cells (arrow). (x40)
Fig. 3.1.1-28 C. parapsilosis, Gram stain on positive blood 
culture sample from bottle.
Fig. 3.1.1-29 C. parapsilosis, culture on CMT agar.
Small cream-coloured dome-shaped glistening colonies 
appear after 48 hours of incubation. 
Colonies are non-haemolytic dome-shaped glistening 
later curling up and becoming lacy. Prominent after 48 
hours.
Fig. 3.1.1-24 C. parapsilosis , culture on chocolate agar. 
Fig. 3.1.1-25 C. parapsilosis, culture on SBA.
C. parapsilosis , culture on chocolate agar
C. parapsilosis, culture on SDA
C. parapsilosis, Gram stain from blood culture
C. parapsilosis, culture on SBA
C. parapsilosis, culture on BiGGY agar
C. parapsilosis, microsopy of CMT agar
Fig. 3.1.1-24
Fig. 3.1.1-26
Fig. 3.1.1-28
Fig. 3.1.1-25
Fig. 3.1.1-27
Fig. 3.1.1-29
Colonies are small and glistening at 48 hours but later 
wrinkle and appear lacy.
Colonies are light brown with a purple or lilac tinge, 
sometimes bordering on grey. Later, colonies curl and 
become lacy. Fig. 3.1.1-27 C. parapsilosis, culture on BiGGY agar.
C. glabrata, culture on chocolate agar
C. glabrata, culture on SDA
C. glabrata, culture on SBA
C. glabrata, culture on BiGGY agar
Fig. 3.1.1-30
Fig. 3.1.1-32
Fig. 3.1.1-31
Fig. 3.1.1-33
Candida glabrata
C. glabrata is both a commensal and environmental pathogen. It can cause mucosal surface infections 
(oropharyngeal, esophageal, and vaginal candidiasis) and is now increasingly isolated in disseminated fungemia.
Tiny white glistening colonies appear at 48 hours.  
Texture is not creamy, more like bacteria.
Similar to chocolate agar, tiny white non-haemolytic 
colonies.
Fig. 3.1.1-30 C. glabrata, culture on chocolate agar. 
Fig. 3.1.1-31 C. glabrata, culture on SBA. 
Colonies are small, glistening at 48 hours but older 
colonies wrinkle up and appear lacy.
Colonies appear off-white.
Fig. 3.1.1-32 C. glabrata, culture on SDA. 
Fig. 3.1.1-33 C. glabrata, culture on BiGGY agar.
Yeasts are oval and smaller than red blood cells, 
approximately 2-4 µm in diameter. Pseudohyphae  
are never seen. (x100)
Yeast cells are small and oval. Pseudohyphae absent. 
(x10)
Fig. 3.1.1-34 C. glabrata, Gram stain from positive blood culture bottle.
Fig. 3.1.1-35 C. glabrata, culture on CMT agar. 
C. glabrata, Gram stain from positive 
blood culture bottle C. glabrata, microsopy of CMT agarFig. 3.1.1-34 Fig. 3.1.1-35
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Colonies are dry, almond-shaped and spreading across 
the plate.
Colonies are dark brown with a brown diffusible 
pigment and a silver metallic sheen. 
Fig. 3.1.1-
38 C. krusei, 
culture on 
SDA. 
Fig. 3.1.1-
39 C. krusei, 
culture on 
BiGGY agar. 
 C. krusei, culture on chocolate agar
C. krusei, Gram stain on positive
blood culture sample
C. krusei, culture on SDA
C. krusei, culture on SBA
C. krusei, microsopy of CMT agar
C. krusei, culture on BiGGY agar
Fig. 3.1.1-36
Fig. 3.1.1-38
Fig. 3.1.1-37
Fig. 3.1.1-41
Fig. 3.1.1-39
Candida krusei
C. krusei results in nosocomial disseminated infections in patients with haematological malignancies or in 
immunosuppressed states.
Colonies are large flat, dry and grey. They resemble the 
large spreading colonies of bacillus. 
Non-haemolytic flat, dry colonies, spreading over the 
agar surface.
Fig. 3.1.1-36 C. krusei, culture on chocolate 
agar. 
Fig. 3.1.1-37 C. krusei, culture on SBA. 
Yeast form is 4-6 µm, almost the same size as RBCs. 
Shape of cells is oval to elliptical. Pseudohyphae may   
be seen. (x100)
Long slender pseudohyphae with elongated 
blastoconidia, aligned both parallel and perpendicular 
to the axis of the pseudohyphae, giving a cross-
matchstick arrangement (arrow). (x40)
Fig. 3.1.1-40 C. krusei, Gram stain on positive blood culture 
sample. 
Fig. 3.1.1-41 C. krusei, culture on CMT agar. 
Fig. 3.1.1-40
C. lusitaniae, culture on chocolate agar
C. lusitaniae, culture on SDA
C. lusitaniae, culture on SBA
C. lusitaniae, culture on SDA
Fig. 3.1.1-42
Fig. 3.1.1-44
Fig. 3.1.1-43
Fig. 3.1.1-45
Candida lusitaniae
C. lusitaniae is a gut commensal that is a very rare cause of invasive infections in patients with prolonged 
neutropenia, bone marrow transplantation or on high-dose cytoreductive chemotherapy.
Small white glistening dome-shaped colonies. Similar to chocolate agar, the colonies are white, 
small, glistening and dome-shaped. Like most yeasts, 
colonies are non-haemolytic.
Fig. 3.1.1-43 C. lusitaniae, culture on SBA. 
White glistening dome-shaped colonies. Uniformly coloured dark brown glistening colonies 
giving the impression of tempered chocolate.
Fig. 3.1.1-44 C. lusitaniae, culture on SDA. 
Fig. 3.1.1-45 
C. lusitaniae, 
culture on 
BiGGY agar. 
Small oval budding yeast cells, 2-4 µm in size. Most do 
not form pseudohyphae in specimen. (x100)
Short curved, branched pseudohyphae, with 
elongated blastoconidia. (x40)
Fig. 3.1.1-46 C. lusitaniae, Gram stain.
Fig. 3.1.1-47 C. lusitaniae, culture on CMT agar. C. lusitaniae, Gram stain C. lusitaniae, microsopy of CMT agarFig. 3.1.1-46 Fig. 3.1.1-47
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Small budding yeast cells oval to elliptical in shape. 
Pseudohyphae usually not seen in clinical specimens. 
(x100)
Small clusters of blastoconidia giving rise to short 
pseudohyphae. Yeast cells are oval to elliptical and 
2-3 µm in size. (x40)
Fig. 3.1.1-53 C. guilliermondii, culture on 
CMT agar. 
Candida guilliermondii
C. guilliermondii is an uncommon skin commensal as well as an environmental pathogen that is associated with 
onychomycosis and superficial cutaneous infections. Rarely seen as a cause of invasive fungal infection.
C. guilliermondii, Gram stain
C. guilliermondii, culture on chocolate agar
C. guilliermondii, culture on SDA
C. guilliermondii, microsopy of CMT agar
C. guilliermondii, culture on SBA
C. guilliermondii, culture on BiGGY agar
Fig. 3.1.1-52
Fig. 3.1.1-48
Fig. 3.1.1-50
Fig. 3.1.1-53
Fig. 3.1.1-49
Fig. 3.1.1-51
Colony morphology is quite similar to C. lusitaniae.  
Small white glistening dome-shaped colonies. 
Growth similar to chocolate agar. Small white 
glistening dome-shaped non-haemolytic colonies.
Fig. 3.1.1-48 C. guilliermondii, culture on chocolate agar. 
Fig. 3.1.1-49 C. guilliermondii, culture on SBA.
Small white glistening dome-shaped colonies. Uniformly coloured brown glistening colonies.
Fig. 3.1.1-51 C. guilliermondii, culture on BiGGY agar. 
C. auris, culture on SBA C. auris, microsopy of CMT agarFig. 3.1.1-54 Fig. 3.1.1-55
Candida auris 
C. auris has recently emerged across the globe as a nosocomial pathogenic Candida species closely related to 
Candida haemulonii. It was first identified as a separate species in a report from South Korea in 2008, and there 
have been reports of outbreaks in Pakistan, Venezuela, South Africa and United Kingdom. The most alarming 
feature of this organism is the ability to develop multi-drug resistance, that is, resistance against two or more 
classes of antifungal agents, including amphotericin. Due to resistance to various group of antifungal drugs, 
morbidity and mortality is higher than other Candida infections.
Small white dome-shaped non-haemolytic colonies  
with a butyrous texture.
Microscopically, the cells are small to medium sized 
oval budding yeasts not forming any pseudohyphae. 
(x40)Fig. 3.1.1-54 C. auris, culture on SBA.
Fig. 3.1.1-55 C. auris, Gram stain. 
Disc diffusion method. 
C. auris is considered 
inherently resistant to 
fluconazole (arrow) and 
is known to acquire 
resistance against 
several antifungal 
classes, including 
amphotericin and 
echinocandins. 
Fig. 3.1.1-58 Susceptibility testing.
C. auris, culture on BiGGY agar
Susceptibility testing
C. auris, culture on BiGGY agarFig. 3.1.1-56
Fig. 3.1.1-58
Fig. 3.1.1-57
Close-up view shows small to medium oval yeasts. Light brown coloured colonies with a white margin.
Fig. 3.1.1-56 C. auris, culture on BiGGY agar.
Fig. 3.1.1-57 C. auris, culture on BiGGY agar.
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Cryptococcus neoformans 
Kauser Jabeen and Joveria Farooqi
C. neoformans is an environmental yeast causing pulmonary, CNS and skin lesions. The most common site 
of entry is lungs where it can cause asymptomatic infection and even life-threatening pneumonia. Serum 
cryptococcal antigen detection test is performed to rule out invasive cryptocosiss. 
It is an important pathogen in morbidities associated with HIV/AIDS and CNS involvement should be ruled out in 
patients at high risk of dissemination. Focus can persist in prostate after therapy for systemic disease and may 
act as a reservoir for relapse in men with AIDS.
Clinical Presentation
Chest radiograph shows complete opacification of the 
right lower lobe.
Axial T1-weighted scans show nodular meningeal 
enhancement with micro-abscesses. There is 
hydrocepahlus. CSF examination was positive for 
Cryptococcus spp.
Fig. 3.1.2-1 Pulmonary cryptococcosis. 
Fig. 3.1.2-2 Cryptococcal meningitis. A (post-contrast) and B (magnified).
CT scan shows consolidation (arrow) in the right lower 
lobe.
Common presentations of cutaneous cryptococcosis 
include papules, maculopapules, ulcers and cellulitis. 
In severely immunosuppressed patients, skin 
manifestations may reflect disseminated cryptococcal 
disease.
Pulmonary cryptococcosis
Pulmonary cryptococcosis
Cryptococcal meningitis. A (post-contrast) 
and B (magnified)
Cutaneous cryptococcosis
Fig. 3.1.2-1
Fig. 3.1.2-3
Fig. 3.1.2-2
Fig. 3.1.2-4
Round budding yeasts with narrow-based budding  
with capsule. (x100)
Round budding cells with halo due to capsule. (x40)
Fig. 3.1.2-5 C. neoformans, Gram stain of 
cerebrospinal fluid.
C. neoformans, Gram stain of cerebrospinal fluid
C. neoformans, PAS stain of lung tissue
C. neoformans, Fontana-Masson 
stain of skin biopsy
C. neoformans, India ink preparation
C. neoformans, PAS stain of skin biopsy
C. neoformans, Gomori methenamine 
silver nitrate stain of skin biopsy
Dark pink round budding yeast cells with surrounding 
capsular artefact. (x40)
Spherical yeast cells with narrow-based budding. 
Thick capsule at times does not allow strong staining 
of yeast cells. (x40)
Cryptococcal cells are stained dark brown to black. (x40) Round black budding yeast cells. (x40)
Fig. 3.1.2-5
Fig. 3.1.2-7
Fig. 3.1.2-9
Fig. 3.1.2-6
Fig. 3.1.2-8
Fig. 3.1.2-10
Fig. 3.1.2-1 Copyright © Elsevier, [Asian Pacific J Trop Dis 5, 2015, S114-5, doi:10.1016/S2222-1808(15)60870-2]
Fig. 3.1.2-3 Copyright © Elsevier, [Asian Pacific J Trop Dis 5, 2015, S114-5, doi:10.1016/S2222-1808(15)60870-2]
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Round budding yeasts (5-7 µm in size) without pseudohyphae with some cells exhibiting multipolar budding. 
(x100)
Round budding yeasts without pseudohyphae. Cryptococcus typically stains gram positive and may be mistaken 
for a lymphocyte. India ink smear should be performed for diagnosis. (x100)
Fig. 3.1.2-12 C. neoformans, Gram stain of smear prepared from positive blood 
culture.
C. neoformans, Gram stain of sputum sample C. neoformans, wet mount preparation C. neoformans, Gram stain
C. neoformans, Gram stain of smear prepared from positive blood culture
Fig. 3.1.2-11 Fig. 3.1.2-12 Fig. 3.1.2-14 Fig. 3.1.2-15
Fig. 3.1.2-13
Ovoid to subspherical budding yeast cells. (x40) Ovoid to subspherical budding yeast cells. (x100)
Mucoid colonies due to presence of capsule. Mucoid colonies due to presence of capsule.
C. neoformans, culture on SBA
C. neoformans, microsopy of CMT agar
C. neoformans, culture on SDA
Urea test
Fig. 3.1.2-16 Fig. 3.1.2-17
Fig. 3.1.2-19
Clusters of round blastospores. (x10) Most Cryptococcus strains are urease positive. 
Fig. 3.1.2-18
Multipolar budding
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Geotrichum spp., culture on SDA agar Fig. 3.1.3-1
Rare Yeasts
Kauser Jabeen and Joveria Farooqi
Geotrichum species
Geotrichum is an environmental organism and part of normal flora in humans, and results in disseminated infection 
in immunosuppressed patients.
Colonies are initially yeast-like but later become dry with development of low aerial mycelia.
Diagnosis of Fungal Infections (Clinical Lesions, Microscopic Examination and Culture)
Trichosporon species
Trichosporon is a skin commensal that results in superficial skin, hair (white piedra) and nail infection. It is the 
second common cause of life-threatening disseminated yeast infections.
True hyphae giving lateral branches at right angle. These lateral branches break into rectangular arthroconidia of 
variable lengths. There are no blastoconidia. Most strains are urease negative. (x10)
Geotrichum spp., photomicrographs of 
slide culture
Trichosporon spp., culture on SDA agar
Trichosporon spp., microscopy of CMT agar
Trichosporon spp., culture on SBA agar
Growth of moist and yeast-like colonies that later 
become dried up with wrinkled heaps at the centre of the 
plate (arrow) in contrast with smooth colonies of Candida. 
Dry wrinkled chalky white colonies (arrow).
True hyphae and pseudohyphae. These hyphae fragment into arthroconidia. Blastoconidia along the hyphae 
may be seen and helps in differentiation of Trichosporon from Geotrichum species. Most strains are urease 
positive. (x100)
Fig. 3.1.3.6 Trichosporon spp., microscopy of CMT agar 
culture.
Fig. 3.1.3-2
Fig. 3.1.3-4
Fig. 3.1.3-6
Fig. 3.1.3-3
Fig. 3.1.3-5
Arthroconidia breaking off from hyphae, 
absence of blastoconidia
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Malassezia furfur
M. furfur is a skin commensal in sebaceous-rich areas of the body, and causes dandruff, seborrheic dermatitis 
and tinea versicolor. It is also a known cause of sepsis in neonates receiving parenteral nutrition with lipid-rich 
supplements. The growth of Malassezia species (with an exception of Malassezia pachydermatis) requires fatty acid 
and therefore this yeast does not grow on routine fungal culture media.
Tinea versicolor, microscopic examination –
Calcofluor white stain (fluorescent) of skin scrapings
Rhodotorula spp., Gram stain from a positive 
blood culture bottle
M. furfur, culture on SDA agar with olive oil overlay
Rhodotorula spp., culture on SDA
Skin scrapings from patient with tinea versicolor  
reveals both yeast and hyphal form – classical  
“spaghetti and meatball appearance”. (x40)
Growth of M. furfur requires fatty acid and in laboratory 
fungal growth media is overlaid with olive oil to 
promote growth as shown in the image. Colonies of 
M. furfur are smooth and yeast-like that later become 
dry and wrinkled. Microscopy of these colonies 
reveals yeast cells with distinct collarettes. 
Fig. 3.1.3.7 Tinea  versicolour, microscopic examination – 
Calcofluor white stain (fluorescent) of skin scrapings.
Fig. 3.1.3.8 M. furfur, culture on CMT agar with olive oil 
overlay.
Rhodotorula species
Rhodotorula is an environmental yeast, known for its distinctive red pigmentation. It results in invasive infections 
in hospitalised patients with hematological malignancies, AIDS, burns, central venous line insertion as well as IV 
drug abusers and patients admitted in the ICU.
Oval budding yeast cells with capsular artefact.  
Presence of capsule may be mistaken as Cryptococcus 
species. (x100)
Colonies grow rapidly and mature in 4 days. Colour of 
colonies is red, reddish orange or pink. Colonies may 
become mucoid due to presence of capsule. 
Fig. 3.1.3.9 Rhodotorula spp., Gram stain from 
a positive blood culture bottle.
Fig. 3.1.3.10 Rhodotorula spp., culture on SDA.
Fig. 3.1.3.7
Fig. 3.1.3.9
Fig. 3.1.3.8
Fig. 3.1.3.10
Diagnosis of Fungal Infections (Clinical Lesions, Microscopic Examination and Culture)
Colonies grow rapidly and mature in 4 days. Colour of 
colonies is red, reddish orange or pink. Colonies may 
become mucoid due to presence of capsule. 
Oval-elongated cells that produce rudimentary 
pseudohyphae. These are urease positive and usually 
grow at 37oC. (x10)
Fig. 3.1.3.11 Rhodotorula spp., culture on SBA.
Initial white, yeast-like colonies that later become raised 
and membranous.
Irregular, elongated, spindle-shaped cells.
Fig. 3.1.3.11 Rhodotorula spp., culture on SBA.
Rhodotorula spp., culture on SBA Rhodotorula spp., microsopy of CMT agarFig. 3.1.3-11 Fig. 3.1.3-12
Ustilago spp., culture on SDA Ustilago spp., wet preparation of colonyFig. 3.1.3-13
Ustilago (Pseudozyma) species
Ustilago is a plant pathogen that is rarely associated with human disease, however, it can cause blood stream 
infections in neonates and immunosuppressed patients. 
Fig. 3.1.3-14
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Clinical Presentation
Table 3.3: Types of Aspergillosis
Hypersensitivity Colonisation Superficial Invasive
• Allergic 
bronchopulmonary 
aspergillosis (ABPA)
• Asthma
• Allergic rhinosinusitis
• Aspergilloma • Keratitis
• Otomycosis
• Sinusitis
• Cutaneous
• Pulmonary 
• Aspergillosis (acute and 
chronic)
• Tracheobronchitis
• Extrapulmonary
• CNS
• Endophthalmitis
• Endocarditis
• Osteomyelitis and arthritis
Invasive pulmonary aspergillosis AspergillomaFig. 3.2-1 Fig. 3.2-2
A. Postero-anterior radiograph of 56-year-old female 
patient shows right middle lobe pneumonia, diffuse 
infiltrates in both lungs and halo sign. 
B. Non-enhanced CT scan shows the centre of the 
consolidated lesion liquefying to turn into a thick-
walled abscess (arrows). Aspergillus spp. was isolated 
from the pus aspirate.
Middle-aged male patient with recurrent haemoptysis. 
A. Postero-anterior radiograph shows a well-defined 
spherical thin-walled cavity in the left middle zone 
(arrow). Note clear “halo” around the opacity. 
B (supine) and C (prone). Non-contrast CT chest in 
lung window settings. Free-lying soft tissue density 
ball in a cavity which changes position with gravity 
(arrow). Appearance consistent with aspergilloma 
(fungal ball) that occurs when inhaled conidia enter 
a pre-existing cavity in lung and germinate to form 
a solid ball of fungal mycelium. Rarely can lead to 
invasive disease.
Diagnosis of Fungal Infections (Clinical Lesions, Microscopic Examination and Culture)
Fungal arthritis and osteomyelitis
Fungal sinusitis extending into intracranial space
A 10-year-old boy presented with history of painful 
swollen left hip and an inability to walk. Coronal 
inversion recovery (STIR) MR of both hips shows 
marrow edema involving the acetabulum and the 
proximal femur (arrow head), joint effusion (white 
arrow) and an intraosseous abscess in the roof of  
the acetabulum (black arrow). Compare with the 
normal right hip. Joint aspirate revealed growth of 
Aspergillus spp. 
Brain abscess
A 26-year-old female patient presented with headache 
and drowsiness. 
A. Axial T2-weighted MRI of brain shows a well-
defined low T2-signal lesion in the right frontal lobe 
with surrounding edema (arrow).
 
B. Axial contrast-enhanced T1-weighted MRI of 
brain shows marked peripheral enhancement (black 
arrow) as well as involvement of the left lateral 
ventricular lining (white arrow). Radiological findings 
are consistent with diagnosis of brain abscess with 
ventriculitis. Similar presentation with tuberculous 
infection. Both the CSF as well as the aspirate from 
the abscess had growth of Aspergillus spp.
A 14-year-old boy with no known co-morbids presented with complaints of reduced vision in left eye and 
headcahes. 
A. Coronal T2-weighted MRI scan shows an expanded sphenoid sinus bulging into the intracranial space. The 
sinus is filled with material which is profoundly low-signal on T2-weighted image resembling air (arrow). 
B (pre-contrast) and C (post-contrast). Coronal T1-weighted scans shows intermediate signal from the mass 
(white arrow) with some enhancement (black arrow). This combination of a profoundly low signal on T2-weighted 
scan and intermediate signal on T1-weighted scan with enhancement is pathognomonic of fungal sinusitis 
secondary to an Aspergillus infection. Fungal sinusitis can be fatal and is mostly seen in tropical countries.
Fig. 3.2-3 Fig. 3.2-4
Fig. 3.2-5
Aspergillus 
Afia Zafar
Over 200 different molds are classified under this species. Found in oxygen-rich and saccharide-rich 
environments, such as on post-harvest crops storage. Aspergillosis includes wide range of clinical diseases, 
which ranges from invasive infections to simple allergies. The most serious form of disease is invasive pulmonary 
Aspergillosis which occurs in immunocompromised hosts and sometime disseminates to other organs. Aspergillus 
fumigatus is the most frequent pathogenic Aspergillus globally but in Pakistan, A. flavus causes most of invasive 
infections followed by A. fumigatus, A. terrus and A. niger. For clinical laboratories, identification of Aspergillus up to 
species level is crucial as variable susceptibilities to antifungal drugs influence the selection of a drug to be used 
for the management of a case. Fungal hyphae are angioinvasive and lead to the formation of mycotic emboli, 
hemorrhages and infarction of tissue.
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Keratitis, Calcofluor white stain
Cutaneous aspergillosis
Allergic bronchopulmonary aspergillosis (ABPA)
A. fumigatus, 10% KOH wet mount smear
Cutaneous aspergillosis, close-up of skin papules
Corneal ulcer scraping shows hyphae. Aspergillus,  
mainly A. fumigatus, is an infrequent cause of infection  
of the cornea after trauma or corneal surgery. (x20)
Septate hyphae seen in sputum. (x40)
Fig. 3.2-6 A. Keratitis, Calcofluor white stain.
Fig. 3.2-6 B. A. fumigatus, 10% KOH wet mount 
smear.
A 32-year-old male patient presented with a 6-month 
history of asymptomatic flesh-coloured papules on  
trunk gradually increasing in number.
Culture shows growth of Aspergillus spp. Patient 
responded to treatment with itraconazole but was lost 
to follow-up.
Fig. 3.2-7 Cutaneous aspergillosis. 
Fig. 3.2-8 Cutaneous aspergillosis, close-up of skin 
papules. 
A 25-year-old female patient known asthmatic 
presented with an episode of haemoptysis.
A. Postero-anterior radiograph of chest shows central 
bronchiectasis with a dilated fluid-filled bronchus at 
the left hilum.
B. Coronal reformatted non-contrast CT of the 
chest better delineates the extent of the central 
brochiectasis and the fluid-filled bronchus. 
Appearances consistent with ABPA.
Fig. 3.2-9 Allergic bronchopulmonary 
aspergillosis (ABPA). 
Aspergillus fumigatus
The most commonly isolated Aspergillus species typically found in soil and compost. A. fumigatus mold cause fatal 
acute pulmonary infection as well as chronic pulmonary infections and allergic bronchopulmonary aspergillosis. It 
is also the most common cause of invasive fungal infection in immunosuppressed individuals. 
Fig. 3.2-6 Fig. 3.2-7
Fig. 3.2-8
Fig. 3.2-10
Fig. 3.2-9
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Day 3, incubation at 37oC. Smoky grey-green and 
velvety-powdery growth. 
Day 3, incubation at 37oC. Smoky grey-green and 
velvety-powdery growth.
Fig. 3.2-10 A. fumigatus, front view of 
culture on SDA.
Fig. 3.2-11 A. fumigatus, front view of culture on 
PDA.
A. fumigatus, front view of culture on SDA
A. fumigatus, reverse view of culture on SDA
A. fumigatus, front view of culture on PDA
A. fumigatus, LPCB wet mount prep
Day 3, incubation at 37oC. White, pale yellow and tan 
coloured colonies.
Septate hyphae, short conidiophore, flask-shaped 
vesicles, uniseriate phialides (only on upper two-thirds 
of vesicle) and columnar conidia. (x40)
Fig. 3.2-12 A. fumigatus, reverse view of culture on 
SDA.
Fig. 3.2-13 A. fumigatus, LPCB wet mount prep.
Fig. 3.2-11
Fig. 3.2-13
Fig. 3.2-12
Fig. 3.2-14
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A. flavus, front view of culture on SDA A. flavus, front view of culture on SDA
Aspergillus flavus
Mold found in warm humid soil as well as coloniser of nuts, seeds and legumes where it produces A. flavus toxin. 
It can cause the complete spectrum of aspergillosis. A. flavus is unique in its ability to be thermo-tolerant and be 
able to survive extremes of temperature.
Day 4, incubation at 37oC. Initial yellow growth which 
quickly turned bright to dark yellow-green, lime and 
olive-green.
Yellow to green coloured colonies.
Fig. 3.2-14 A. A. flavus, front view of culture on SDA. 
Fig. 3.2-15 A. A. flavus, front view of culture on PDA.
Fig. 3.2-15 Fig. 3.2-16
A. flavus, reverse view of culture on PDA
A. flavus, LPCB wet mount preparation
A. nidulans, front view of culture on SDA
A. flavus, reverse view of colony on PDA
A. nidulans, reverse view of culture on SDA
Day 4. Tan to white  on reverse. Creamy white to yellow colour. 
Fig. 3.2-15 B. A. flavus, reverse view of colony on 
PDA.
Fig. 3.2-15B
Septate hyphae, long 
conidiophore, uniseriate 
and (mostly) biseriate 
phialides, and numerous 
conidia. (x40)
Aspergillus nidulans 
Day 4, incubation at 37oC. Rapid growing velvety green 
to buff colonies.
Day 4, incubation at 37oC. Buff to brown reverse.
Fig. 3.2-17
Fig. 3.2-19
Fig. 3.2-20 Fig. 3.2-21
Fig. 3.2-18
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Smooth brown pigmented stalk, hemispherical vesicle 
with metulae and phialides. (x40)
Close-up of vesicle. (x40)
A. nidulans, LPCB wet mount preparation
A. nidulans, LPCB wet mount preparation
A. nidulans, LPCB wet mount preparation
Thick-walled globose 
Hülle cells. (x40)
Fig. 3.2-22
Fig. 3.2-24
Fig. 3.2-23
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A. terreus, front view of culture on SDA A. terreus, reverse view of culture on SDAFig. 3.2-25 Fig. 3.2-26
Aspergillus terreus
A. terreus is a mold ommonly found in soil, compost and dust, and used industrially to produce organic acids and 
enzymes. Infection mostly manifests as otomycosis and onychomycosis as well as disseminated invasive disease. 
Day 3, incubation at 37oC. Velvety tan to cinnamon 
brown growth.
Day 3, incubation at 37oC. Pale brown reverse.
Septate hyphae, relatively short conidiophore, biseriate phialides covering upper half of vesicle, and round and 
smooth conidia. (x40)
A. niger, front view of culture on SDA
A. terreus, LPCB mount
A. niger, reverse view of culture on SDA
A. niger, LPCB wet mount preparation
Fig. 3.2-28
Fig. 3.2-27
Fig. 3.2-29
Fig. 3.2-30
Aspergillus niger
A. niger is a mold found in soil and indoor environment, affecting fruits and vegetables. It is one of the most 
common causes of otomycosis which can result in otalgia, hearing loss and at times permanent damage to 
tympanic membrane.
Day 3, incubation at 37oC. Surface granular in texture 
with whitish colouration that rapidly turned black at  
the centre. 
Day 3, incubation at 37oC. Creamy white to yellow 
surface.
Three long conidiophores arising from septate hyphae. The central vesicles are completely covered with conidia. 
(x40)
Diagnosis of Fungal Infections (Clinical Lesions, Microscopic Examination and Culture)
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Mucoraceous Molds 
Kauser Jabeen
Mucorales
Mucorales includes Rhizopus, Mucor and Lichtheimia molds known for their characteristic black colour and 
angioinvasive manifestations. Central nervous system mucormycosis is mostly seen as an extension from nose 
or paranasal sinus with a blackish discharge while acute and rapidly fatal gastrointestinal mucormycosis is 
seen in patients with extreme malnutrition. Treatment consists of intravenous anti-fungal (lipid formulations of 
amphotericin B are first-line) and surgical excision of the infected tissue whenever feasible.
Clinical Presentation
Table 3.4: Types of mucormycosis
• Central nervous system mucormycosis
• Rhinocerebral mucormycosis
• Sinopulmonary mucormycosis
• Gastrointestinal mucormycosis
• Disseminated mucormycosis
• Rare: 
• Endocarditis
• Osteomyelitis
• Isolated cerebral, renal and peritoneal disease
• Chronic subcutaneous infection
A. Axial T2-weighted image shows edema and  
induration of the left cheek and the left nasolabial fold 
along with diffuse sinus disease. 
B (pre-contrast) and C (post-contrast). Axial T1-
weighted images show an inflammatory mass with 
enhancement. Most commonly seen in diabetics. 
Patients present with facial pain and headache, and 
development of black ulcers reflects characteristic tissue 
necrosis.
High resolution CT (HRCT) of chest from a 
diabetic patient with pulmonary mucormycosis 
showing consolidation and cavitation in the right 
middle lobe. Seen mostly in patients with severe 
immunocompromise. Patients with COPD on 
chronic steroid treatment are also at risk. Subacute 
presentation is seen in some patient populations. 
Rhinocerebral mucormycosis Pulmonary mucormycosisFig. 3.3-1 Fig. 3.3-2
Orbital mucormycosis
Cutaneous mucormycosis Soft tissue mucormycosis
Cutaneous mucormycosisFig. 3.3-3
Fig. 3.3-5 Fig. 3.3-6
Fig. 3.3-4
Non-contrast CT of the orbits shows left-sided  
proptosis and infiltration of the retrobulbar fat. The  
orbital globe is deformed consistent with necrosis. The 
patient had poorly controlled diabetes and presented 
with loss of vision in the left eye along with periorbital 
ecchymosis and facial pain. Eventration of the orbit was 
carried out. Histopathology revealed broad non-septate 
hyphae consistent with mucormycosis.
Typical tissue necrosis. Due to angioinvasive nature  
of mucoraceous molds, there is ischemia, necrosis 
and genagrene of tissue. Predominantly involves 
epidermis and dermis.
Tissue gangrene. Infection is often secondary to 
trauma, burn, surgery, systemic infection at any other 
site, and use of contaminated dressings.
Plain x-ray shows soft tissue defect in the popliteal 
and infrapopliteal region of the left lower limb.
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Fig. 3.3-2 Copyright © AME Publishing Company, [J Thorac Dis 9, 2017, E121-E125, doi:  10.21037/jtd.2017.02.31] Fig. 3.3-6 Copyright © Wiley Online Library, [Int Wound J 8, 2011, 651-5, doi:  10.1111/j.1742-481X.2011.00839.x.]
Growth of fluffy mucoraceous molds at tissue incubated 
at room temperature.
Typical ribbon-like aseptate hyphae. (x40)
Fig. 3.3-9 Mucorales, growth on tissue on gross examination.
Fig. 3.3-10 Mucorales, microscopy on 10% KOH wet 
mount smear.
Mucorales, growth on tissue on gross examination Mucorales, microscopy on 10% KOH wet mount smearFig. 3.3-7 Fig. 3.3-8
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Mucorales, microscopy on 10% KOH wet mount smear
Mucorales, H&E stain of tissue
Mucorales, culture on SDA
Mucorales, Gram stain
Mucorales, H&E stain of muscle tissue
Mucorales, culture on SDA
Fig. 3.3-10
Fig. 3.3-12
Fig. 3.3-14
Fig. 3.3-11
Fig. 3.3-13
Typical ribbon-like aseptate hyphae. (x40) Hyphae of mucoraceous molds.(x100)
Fig. 3.3-9
Broad aseptate hyphae. (x100) Broad aseptate hyphae. (x100)
Fig. 3.3-13 Mucorales, H&E stain of tissue.
Fig. 3.3-14 Mucorales, H&E stain of muscle tissue.
Rapid growth of mucoraceous molds within 12 hours of 
inoculation.
Rapidly growing lid lifter colonies filling the petri dish.
White to pale grey colonies. White to pale grey colonies.
Absidia corymbifera, culture on SDA
Rhizopus spp., culture on SDA
Rhizopus spp., LPCB wet mount preparation
Apophysomyces spp., LPCB wet mount preparation
Mucor spp., culture on SDA
Rhizomucor spp., LPCB wet mount preparation
Absidia spp., LPCB wet mount preparation
Saksenaea vasiformis, LPCB wet mount 
preparation
Fig. 3.3-16
Fig. 3.3-18
Fig. 3.3-20
Fig. 3.3-22
Fig. 3.3-15
Fig. 3.3-17
Fig. 3.3-19
Fig. 3.3-21
Grey-to-black older colonies around the rim of the plate. Round sporangia and internodal rhizoids. (x40)
Round sporangia and nodal rhizoids. (x10) Small pear-shaped sporangia. (x10)
Pear-shaped sporangia and prominent apophysis  
(arrow). This mold is very difficult to sporulate. (x40)
Flask-shaped sporangia. This mold is very difficult to 
sporulate. (x40)
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Fig. 3.3-11 Copyright © Wiley Online Library, [Int Wound J 8, 2011, 651-5, doi:  10.1111/j.1742-481X.2011.00839.x.]
Fig. 3.3-12 Copyright © Wiley Online Library, [Int Wound J 8, 2011, 651-5, doi:  10.1111/j.1742-481X.2011.00839.x.]
Finger-like tubular sporangia arranged on a vesicle. (x40) Vesicles covered with spine-like denticles. (x40)
Syncephalastrum spp., LPCB wet mount preparation Cunninghamella spp., LPCB wet mount preparation Fig. 3.3-24Fig. 3.3-23
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Subcutaneous entomophthoromycosis
Basidiobolus spp., LPCB wet mount preparation
Chronic subcutaneous infection
Conidiobolus spp., culture plate
Fig. 3.3-26
Fig. 3.3-28
Fig. 3.3-25
Fig. 3.3-27
Entomophthorales 
In immunocompetent hosts, Entomophthorales cause distinct cutaneous syndromes (entomophthoromycosis). In 
immunocompromised hosts, the species causes rare opportunistic pulmonary and disseminated infection similar 
to that of Mucorales fungi. Some species have a predilection for certain sites:
• Basidiobolus ranarum is a cause of subcutaneous infection, also known as basidiobolomycosis.
• Conidiobolus coronatus or Conidiobolus incongruous is the most common cause of rhinofacial infection, also 
known as conidiobolomycosis.
Clinical Presentation
Extensive tissue ischemia and necrosis secondary to 
infection with Basidiobolus spp.
Visible deformation of facial contours secondary to 
infection with Conidiobolus spp.
Club shaped spores and intercalary zygospores. (x100) White colonies.
Direct microscopy from tissue biopsy reveals parrot 
beak shaped zygospore. (x40)
Single-celled round spores that later bear a broad 
tapering projection. (x40)
Basidiobolus spp., wet mount preparation Conidiobolus spp., LPCB wet mount preparationFig. 3.3-29 Fig. 3.3-30
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 º dermatophytes nxt page
Dermatophytes
Afia Zafar
Dermatophytes are a group of closely related fungi that can be described as anthropophilic, zoophilic or geophilic 
depending upon whether their normal habitat is human being, animal or soil. Dermatophytoses or infection of 
superficial keratinised tissues (skin, nail and hair) are characterised by ring-shaped lesion. Skin scrapings show 
hyaline septate branching hyphae or arthroconidia. 
Table 3.5: Dermatophytes
Epidermophyton Trichophyton Microsporum
E. floccuosum T. mentagrophytes
T. rubrum
T. verrucosum 
T. tonsurans 
T. violaceum 
M. canis
M. audouinii 
M. equinum
M. fulvum
M. gypseum
Table 3.6: Types of dermatophytoses
• Tinea capitis (head)
• Tinea barbae (face)
• Tinea corporis (body)
• Tinea unguinum (nail)
• Tinea pedis (foot)
Tinea corporis Tinea barbae with secondary bacterial infectionFig. 3.4-1 Fig. 3.4-2
Clinical Presentation
Female patient presented with a 3-week history of itchy 
rash on chest and recent development of erythematous 
annular plaques of variable sizes. Lesions resolved after 
treatment with systemic and topical antifungals.
Male patient presented with 2-month history of itchy 
erythematous rash with inflammatory papules and 
pustules localised to coarse facial hair (beard). Lesions 
resolved after improvement in hygiene and treatment 
with systemic and topical antifungals, and antibiotics.
Fig. 3.4-1 Tinea corporis. 
Fig. 3.4-2 Tinea barbae with secondary bacterial infection. 
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Patient presented with 3-month history of progressive 
thickening and discolouration of nail plate with 
paronychia. Responded to 2-month long pulse therapy 
with itraconazole.
Ridging, onycholysis, thickening and discolouration of 
nail plate. Visible inflammation of nails folds.
Fig. 3.4-6 Tinea unguium. 
Tinea capitis
Onychomycosis
Tinea corporis
Tinea unguium
Fig. 3.4-3
Fig. 3.4-5
Fig. 3.4-4
Fig. 3.4-6
Patient presented with 6-week history of patchy hair loss, 
erythema, nodular and pustular lesions, kerion formation, 
and scarring. Lesions resolved after treatment with 
systemic terbinafine for 8 weeks and topical antifungal. 
Female patient presented with 1-month history of an 
itchy and enlarging annular plaque lesion on leg. 
Treated with topical antifungals.
Fig. 3.4-3 Tinea capitis. 
 Fig. 3.4-4 Tinea corporis. 
Young patient presented with 3-week history of 
pruritic and crusting annular concentric rings on face. 
Responded to treatment with topical antifungals and 
improved hygiene. 
Young patient presented with 3-week history of 
erythematous and scaly plaques on face. Treated with 
topical antifungals.
Fig. 3.4-8 Tinea facei. 
Tinea imbricata (Tokelau) caused 
by Tinea concentricum Tinea facei Fig. 3.4-8Fig. 3.4-7
Tinea pedis (before treatment) Tinea pedis (after treatment)Fig. 3.4-9 Fig. 3.4-10
Patient presented with a 5-week history of intertriginous 
dermatitis of toes that spread to involve the sole of the 
foot. Characterised by peeling, maceration and fissuring 
of skin. 
Patient responded to 6-week therapy of oral 
terbinafine and topical antifungals, and improved 
hygiene. 
Fig. 3.4-9 Tinea pedis (before treatment). 
Fig. 3.4-10 Tinea pedis (after treatment). 
Tinea corporis OnychomycosisFig. 3.4-11 Fig. 3.4-12
Patient presented with 2-week history of multiple, itchy 
annular plaques on arm. Responded to topical 
antifungals.
Patient presented with 12-month history of nail 
dystrophy of one toe nail gradually involving all toe 
and finger nails on both hands and feet. There was 
progressive discolouration, thickening and crumbling 
of nail plates with some degree of onycholysis. Treated 
with oral terbinafine.
Fig. 3.4-11 Tinea corporis. 
Fig. 3.4-12 Onychomycosis. 
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Female patient presented 
with 5-month history of 
discrete and confluent 
asymptomatic patches of 
hypo- and 
hyperpigmentation with 
mild scaling on face. The 
lesions gradually 
extended to involve the 
trunk. Treated with 
topical antifungals and 
systemic fluconazole 
(weekly for 1 month), and 
counselled about 
improving hygiene. The 
causative agent is 
Malassezia furfur.
Fig. 3.4-13 Pityriasis versicolour. 
Pityriasis versicolour Fig. 3.4-13
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M. canis, reverse view of culture on SDA
M. canis, LPCB wet mount preparation
M. canis, front view of culture on SDA
M. canis, LPCB wet mount preparation
Fig. 3.4-15Fig. 3.4-14
Fig. 3.4-16 Fig. 3.4-17
Microsporum canis 
M. canis is typically hosted by cats and dogs (zoophilic), and causes infections in humans through transmission 
by direct and indirect contact. It is the most common cause of tinea capitis and tinea corporis in humans. On 
microscopic examination, it displays characteristic macroconidia as well as microconidia.
Slow growing (5 cm in 1 week), pale buff to white colony, 
with yellow to colourless radiating edge.
Bright yellow to colourless at the edge. 
Fig. 3.4-14 M. canis, front view of culture on 
SDA.
Fig. 3.4-15 M. canis, reverse view of culture on 
SDA.
Predominantly large macroconidia concetrated in the 
centre of the colony. (x10)
Spindle-shaped microconidium with rough thickened 
wall and curved to one side. (x40)
Fig. 3.4-16 A. M. canis, LPCB wet mount preparation.
Fig. 3.4-16 B. M. canis, LPCB wet mount 
preparation.
Microsporum gypseum
M. gypseum is commonly found in humid soil (geophilic), and results in hair, skin and nail infections.
M.  gypseum, front view of cultureM.  gypseum, front view of culture on SDA
M.  gypseum, LPCB wet mount preparation
Fig. 3.4-18
Fig. 3.4-20
Fig. 3.4-19
Slow growing colony (4-5 cm in 1 week), powdery in 
texture and buff to cinnamon colour.
Buff to pinkish colour colony.
Fig. 3.4-17 A. M.  gypseum, front view of culture on SDA.
Fig. 3.4-17 B. M.  gypseum , reverse view of culture.
Numerous macroconidia and very few microconidia. Macroconidia are elliptical with thin roughend walls and 4-6 
septa. (x40)
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T. rubrum, LPCB wet mount preparationT. rubrum, reverse view of culture plate Fig. 3.4-21 Fig. 3.4-22
Trichophyton rubrum
T. rubrum is an obligate human pathogen not found in environment. It is a common cause of athlete’s foot, ring 
worm and jock’s itch.
Deep red, brown, yellow and orange coloured colony. 
White granular or fluffy colonies on front.
Sparse clubbed microconidia, formed along the sides 
of the hyphae. Macroconidia absent. (x10)
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Aleurosporulation. (x40)
T. rubrum, LPCB wet mount preparation
T. mentagrophytes, LPCB wet mount preparation
Fig. 3.4-23
Fig. 3.4-24
Trichophton mentagrophytes 
T. mentagrophytes is found in warm and humid places such as swimming pools and public showers, and results in 
tinea capitis, tinea corporis, and tinea pedis. 
Culture on SDA shows flat powdery to granular colonies that appear white to cream on front and cream to brown 
on reverse with radiations (not shown).
Numerous round, smooth-walled micronidia along branching hypae. Typically found in dense clusters. 
Macroconidia are cylindrical with thin walls and 3-4 septa. Sometimes spiral hypae are seen (not shown). (x40)
Fig. 3.4-22 T. mentagrophytes, LPCB wet mount preparation.
Trichophyton tonsurans
T. tonsurans is found in indoor environments, and causes tinea capitis and tinea corporis.
Colonies on SDA are white powdery, flat sometime folded in the centre in the front and yellow to reddish brown on 
reverse (not shown).
(A) Abundant microconidia, large oval to club shaped, growing alongside hyphae; (B) Numerous macroconidia; 
(C) Up to 10 septa sometime loose content and structure. (x40)
Fig. 3.4-23 A, B and C. T. tonsurans, LPCB 
wet mount preparation.
T. tonsurans, LPCB wet mount preparation Fig. 3.4-25
A B C
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Mixed culture of T. violaceum and T. tonsurans, front view of culture plate on SDA
Trichophyton violaceum 
T. violaceum is commonly found in environment, and usually isolated in tinea capitis. Microscopically, T. violaceum 
reveals septate hyphae, often distorted, with micro- and macroconidia extremely rare (not shown). 
Glabrous textured, heaped-up purple-to-deep red colonies of T. violaceum (marked by arrow) growing on SDA 
from skin scrapings of a taenia imbricata patient. Larger buff-coloured felt-like colonies of T. tonsurans can also 
be observed arising from the same site. Both isolates have the same colour on front and reverse. Growth of T. 
violaceum is very slow, taking more than 7 days; T. tonsurans is relatively faster, taking 4-5 days.
Fig. 3.4-24 Mixed culture of T. violaceum and T. tonsurans, front view of 
culture plate on SDA.
Fig. 3.4-26
Epidermophyton flocculosum
E. flocculosum is a common flora of humans, domesticated and wild animals, and found in gyms and showers. It 
is known to cause tinea pedis, tinea cruris, tinea corporis and onychomycosis. 
Culture on SDA shows flat, powdery khaki colonies with colourless submerged edges in front and pale brown on 
reverse (not shown).
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Hyaline Molds 
Kauser Jabeen and Joveria Farooqi
The fungi causing hyalohyphomycosis are characterised by the presence of septate, hyaline and non-pigmented 
hyphae. Notable fungi in this group include Fusarium, Penicillium, Scedosporium, Acremonium, Paecilomyces, 
Trichoderma and Scopulariopsis. Depending on the immune status of the host, infection caused by these fungi 
varies from colonisation, superficial infections and subcutaneous infections to disseminated diseases. Most 
fungi in this group cause life-threatening opportunistic infections. Many of the hyaline molds exhibit decreased 
susceptibilities to several antifungal agents.
Clinical Presentation
Computed tomography scan of chest shows two thick-walled cavities in right lung resulting from Scedosporium 
apiospermum. The first cavity measuring 4.2 by 2.4 cm has a small fungal ball. The second larger cavity (10 by 
4.5 cm) in the right lower lobe has a fungal ball measuring 47 by 29 mm, which extends across major fissure to 
involve the upper lobe as well. 
Fig. 3.5-1 Pneumonia secondary to Pseudallescheriasis. 
Pneumonia secondary to Pseudallescheriasis Fig. 3.5-1
E. flocculosum, LPCB wet mount preparation Fig. 3.4-27 Fig. 3.4-28
Predominantly oval- and club-shaped macroconidia with smooth medium thickness walls and 2-4 septa. (x40)
Fig. 3.4-25 A and B. E. flocculosum, LPCB 
wet mount preparation.
Nodular lesion caused by Fusarium species. An ulcerative lesion caused by S. apiospermum.
Fig. 3.5-2 
Chronic skin 
infection. 
Fig. 3.5-3 
Chronic skin 
infection. 
Chronic skin infection Chronic skin infectionFig. 3.5-2 Fig. 3.5-3
Fig. 3.5-1 Copyright © Springer, [Infection, 44, 2016, 127-32, doi:  10.1007/s15010-015-0840-4]
Long septate macroconidia arising in a cluster
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Fig. 3.5-4 Fig. 3.5-5
Acremonium species
Acremonium is an environmental pathogen typically found in soil, and infection is secondary to penetrating 
trauma. Common agent of nail infections, mycetoma and corneal infections, and can cause disseminated 
infections in immunosuppressed patients.
Nail infection caused by Acremonium species. Coronal contrast-enhanced CT scan reveals 
cardiomegaly, a right-sided aortic arch and 
dehiscence of the ventricular septal defect repair. 
There is focal thickening at the aortic valve and margin 
of the reformed VSD (arrow). Acremonium was cultured 
on surgically excised valve tissue. 
Fig. 3.5-4 Onychomycosis.
Fig. 3.5-
5 Cardiac 
vegetation. 
Onychomycosis
Acremonium spp., front view of culture on SDA
Cardiac vegetation
Acremonium spp., microscopic examinationFig. 3.5-6 Fig. 3.5-7
Colonies grow rapidly and mature in 5-7 days. Texture of 
colonies could be powdery, cottony or felt like. Colour of 
colonies will vary according to species to white, light 
pink, pale rose, yellowish with a colourless reverse.
Septate hyphae arranged in distinct bundles. 
Conidiophores are long, erect and delicate; they bear 
clusters of conidia arranged as wet masses on the tip. 
These conidia are easily disrupted from the tip of 
conidiophore. (x10)
Fig. 3.5-6 A. 
Acremonium 
spp., front 
view of 
culture on 
SDA.
Fig. 3.5-6 B. 
Acremonium 
spp., 
microscopic 
examination.
Diagnosis of Fungal Infections (Clinical Lesions, Microscopic Examination and Culture)
Septate hyphae and typical canoe-shaped macroconidia. The mold was later identified as Fusarium species. 
(x100)
Fig. 3.5-7 
Fusarium spp., 
Gram stain 
from positive 
blood culture 
sample.
Fusarium spp., front view on SDA Fusarium spp., LPCB wet mount preparation
Colonies grow rapidly and mature in 3-5 days. Colonies 
are initially white but later may develop pink, orange, 
purple or peach tinge depending on species. Reverse is 
pale but may be dark depending on species.
Septate hyphae with short tapering conidiophore 
(conidiophore may be long in some species) are seen. 
These conidiophore bear sickle-shaped, banana-
shaped or canoe-shaped macroconidia with three to 
five septa. Sparse to abundant microconidia arranged 
singly or in slimy balls could also be seen depending 
on species. (x40)
Fig. 3.5-7 B 
Fusarium spp., 
front view on 
SDA. 
Fig. 3.5-7 
C Fusarium 
spp., LPCB 
wet mount 
preparation.
Fusarium species
Fusarium is commonly found in soil and debris, and inoculation occurs following trauma, instrumentation or 
insertion of contaminated central venous lines. In immunocompetent patients, Fusarium may cause superficial 
nail and soft tissue infections as well as peritoneal and osteoarticular infections. Populations that are most at 
risk for invasive disease are patients with hematological malignancies and bone marrow transplant patients. 
Cutaneous lesions are present in 60 to 80 per cent of disseminated fusariosis, and blood cultures are frequently 
positive. The characteristic feature of Fusarium species on culture is the production of sickle-shaped multiseptate 
macroconidia.
Fig. 3.5-8
Fig. 3.5-9 Fig. 3.5-10
Fusarium spp., Gram stain from positive blood culture sample
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Colonies grow rapidly and mature in 5 to 7 days. Front 
view initially shows colonies that are white but later  
turn grey. 
Initially white and then turns dark brown or black.
Fig. 3.5-8 A. S. apiospermum, front view of culture 
(medium missing?).
Fig. 3.5-8 B. S. apiospermum, reverse view of 
culture (medium missing?).
Scedosporium apiospermum
S. apiospermum, front view of culture on SDA
S. apiospermum, LPCB wet mount preparation
S. apiospermum, reverse view of culture on SDA
Septate hyphae with 
short and long 
conidiophores. These 
conidiophore bear oval 
conidia arranged singly 
or in small clusters. 
Occasionally 
conidiophores are 
arranged in bundles 
(Graphium state) that 
diverge and at the edge 
bear single conidia. The 
sexual stage can be 
induced by subculturing 
on CMT or PDA. 
Ascocarps are black and 
round with elliptical 
ascospores. (x40)
Fig. 3.5-9 S. 
apiospermum, 
LPCB wet 
mount 
preparation.
Scedosporium prolificans
Colonies grow rapidly and mature in 5 days. Colonies are grey to brownish, spreading, with scant, cobweb 
appearance (not shown). On reverse view, colonies appear dark grey to black. 
On microscopy, septate hyphae bearing short conidiophores are seen. Conidiophores have swollen base and 
long tapering tip that bear conidia singly or in clumps at the apex. Conidia are pigmented, oval or round with a 
truncated base.
Fig. 3.5-11
Fig. 3.5-13
Fig. 3.5-12
Diagnosis of Fungal Infections (Clinical Lesions, Microscopic Examination and Culture)
Scedosporium species
Scedosporium is mainly found in the environment and can be responsible for a spectrum of infections ranging 
from mycetoma to disseminated infections depending on host immunity status. The species is notorious due to 
its neurotropic tendency and antimicrobial resistance. Clinically significant species are S. apiospermum, S. boydii 
and S. prolificans. S. prolificans especially is resistant to virtually all antifungal classes and is associated with high 
mortality.
Paecilomyces species
Paecilomyces have been rarely implicated as a cause of invasive infection in immunosuppressed patient and skin 
infection in immunocompetent patients. Morphologically they resemble Penicillium species, however, their colonies 
are never green or blue-green and they have long, slender and divergent phialides.
Paecilomyces variotii
Colonies grow rapidly and mature in 3-5 days, are olive brown in colour with a pale reverse (not shown). 
On microscopy, phialides are elongated, swollen at bases and taper into a long neck. These phialides may occur 
singly, in pairs, in leaf-like pattern or in brush-like pattern (not shown). 
Purpureocillium lilacinum 
Colonies are white changing to lilac with a pale or deep purple reverse.
Phialides are densely 
clustered. These 
phialides bear long 
divergent chains of 
hyaline to pigmented, 
smooth or rough, sub-
spherical to oval single-
celled conidia.
Previously called 
Paecilomyces lilacinum. 
(x10)
Fig. 3.5-10. 
P. lilacinum, 
LPCB wet 
mount 
preparation. P. lilacinum, LPCB wet mount preparation Fig. 3.5-14
Trichoderma spp., front view of culture on SDA Trichoderma spp., LPCB wet mount preparation
Trichoderma species
Trichoderma is commonly found in soil as well as air. Its typical clinical manifestations include localised cutaneous 
lesions, peritonitis complicating peritoneal dialysis, pulmonary disease (fungus ball), and disseminated infections. 
Antimicrobial activity is variable and surgical resection of localised infection is recommended whenever feasible. 
Colonies grow rapidly, fill the petri dish and mature in 5 
days. Colour of colonies is initially white and later 
develops green patches with a colourless or tan reverse.
On microscopy hyphae are septate and bear short and 
often branched conidiophores. Conidiophores have 
phialides with broad bases and narrow apex that in 
turn have clusters of round, single celled conidia. (x10)
Fig. 3.5-11 A. 
Trichoderma 
spp., front 
view of 
culture on 
SDA.
Fig. 3.5-11 B. 
Trichoderma 
spp., LPCB 
wet mount 
preparation.
Fig. 3.5-15 Fig. 3.5-16
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Penicillium species 
Penicillium is commonly found in soil, damp objects and spaces, and can contaminate food (most common cause 
of spoilage of fruits and vegetables). Characterised by their blue and green colour due to the large quantities of 
green, blue and yellow spores produced. 
Colonies are bluish grey-green, later turning yellowish  
red with diffusible red pigment. This species is the only 
dimorphic Penicillium species, converting to white to  
tan, dry, soft yeast-like colonies at 37oC in 7-14 days  
on SBA or Brain Heart Infusion agar.
Microscopic morphology of Penicillium species 
resembles a broom: phialides consist of 3-5 metulae, 
depending on species, and chains of spherical to oval 
conidia arising in basipetal pattern. The absence of a 
vesicle differentiates it from Aspergillus spp., while 
multiple phialides arising from a single conidiophore 
distinguish it from Scopulariopsis spp.
Fig. 3.5-12 A. 
P. marneffei, 
front view of 
culture on 
SDA. 
Fig. 3.5-13 A. 
P. marneffei, 
LPCB wet 
mount 
preparation.
P. marneffei, front view of culture on SDA P. marneffei, LPCB wet mount preparation
Chrysosporium species
Commonly found in soil and debris as well as indoors in damp wood, cellulose structures and wallpaper. 
Chrysosporium spp. can result in severe invasive disease in immunosuppressed patients. Unlike Penicillium, it 
produces pyriform conidia with truncated bases.
Colonies grow rapidly and mature in 5-7 days. 
Depending on species colour of colonies varies from 
white to tan to pink or light orange with a white or tan 
reverse (highly variable depending on species).
On microscopy, septate hyphae are seen. 
Conidiophores can be of variable length and branched 
and unbranched. Conidia are single-celled and 
club-shaped and grow directly along the hyphae or on 
the conidiophore. Intercalary cylindrical conidia are 
occasionally seen. (x10)
Fig. 3.5-14 A Chrysosporium spp., front view on SDA.
Fig. 3.5-14 B Chrysosporium spp., LPCB wet mount 
preparation.
Chrysosporium spp., front view on SDA Chrysosporium spp., LPCB wet mount preparation
Scopulariopsis species
Scopulariopsis is a common filamentous fungus found indoors in carpets, flooring, cellulose structures and 
swimming pools. It can cause a range of diseases from superficial infection such as onychomycosis to locally 
invasive soft tissue infections and disseminated disease in immunosuppressed patients. Scopulariopsis produces 
conidiophores that closely resemble that of Penicillium species.
Fig. 3.5-17 Fig. 3.5-18
Fig. 3.5-19 Fig. 3.5-20
Diagnosis of Fungal Infections (Clinical Lesions, Microscopic Examination and Culture)
Rapid growing colony 
that matures in 5 days. 
Colonies are initially 
white but turn light 
brown (sandy brown) on 
standing. On reverse, 
colonies are powdery 
with a tan colour.
Fig. 3.5.2-
31 A. 
Scopulariopsis 
spp., front 
view on SDA.
Scopulariopsis spp., front view on SDA
Scopulariopsis spp., LPCB wet mount preparation
Fig. 3.5-21
Fig. 3.5-22
Septate hyphae with short 
conidiophores terminating 
in branched heads with 
cells that are swollen at 
base and narrow at apex. 
These cells bear chains of 
lemon-shaped, rough and 
thick-walled conidia with 
a flattened base. (x40)
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Dematiaceous fungal infections
Chromobalstomycoses
Nodular and cauliflower-
like subcutaneous lesions 
containing sclerotic bodies 
Pheohyphomycoses
Yeast-like cells and 
varied hyphal forms
Allergy
Cutaneous & 
Subcutaneous
Systemic
Pulmonary
CNS
Disseminated
Other sites
Eumycetomas
Chronic tumour-like lesion 
with draining sinuses and 
granules in pus
Diagnosis of Fungal Infections (Clinical Lesions, Microscopic Examination and Culture)
Fig. 3.6-5 Fig. 3.6-6Phaeohyphomycosis, 10% KOH wet mount Phaeohyphomycosis, Gram stain
Smear from patient with brain abscess shows numerous 
pigmented hyphae. (x10)
Stain sample from a patient with brain abscess shows 
pigmented septate hyphae. (x100)
Fig. 3.5.2-5 Phaeohyphomycosis, 10% KOH 
wet mount.
Fig. 3.5.2-6 Phaeohyphomycosis, Gram 
stain.
The lesions are characteristically situated in exposed 
body parts. They are deeply penetrating infections 
resulting in sinus formation and hardening of surrounding 
tissue. The pus draining from the sinuses shows granules 
which may be pigmented (melanised fungi), whitish 
(aerobic Actinomyces such as Nocardia) or yellow 
(Actinomyces). 
Mount of a eumycetoma granule showing distorted 
septate hyphae which may themselves be pigmented 
or secreting a dark pigment into the surrounding 
tissue. (x40)
Fig. 3.5.2-7 
Eumycetoma. 
Fig. 3.5.2-8 
Eumycetoma, 
10% KOH 
wet mount 
smear.
Eumycetoma Eumycetoma, 10% KOH wet mount smearFig. 3.6-7 Fig. 3.6-8
Fig. 3.6-1
Fig. 3.6-3
Fig. 3.6-2
Fig. 3.6-4
Clinical Presentation
Chromoblastomycosis
Phaeohyphomycosis
Chromoblastomycosis
Phaeohyphomycosis, H&E stain
Nodular subcutaneous lesions with cauliflower-like 
outgrowths on exposed areas of the body (hands, feet 
and face).
Nodular subcutaneous lesions with cauliflower-like 
outgrowths on exposed areas of the body (hands, feet 
and face).
Fig. 3.5.2-1 Chromoblastomycosis. 
Deep phaeohyphomycoses present as abscesses 
involving one or several organs. This is an image of a 
large brain abscess due to Neoscytalidium species. 
Biopsy of a brain abscess shows golden brown 
septate hyphae. (x40)
Fig. 3.5.2-3 Phaeohyphomycosis. 
Fig. 3.5.2-4 Phaeohyphomycosis, H&E stain.
Dematiaceous Molds and Melanised Fungi 
Joveria Farooqi and Kauser Jabeen
Dematiaceous fungi are a group of fungi with melanin in their cell walls. Being environmental fungi, their sources 
are plant materials and soil. Most lesions arise due to traumatic implantation or inhalation and deep mycoses 
result either from haematogenous dissemination or contiguous invasion.
Lesions may be divided into three main categories on the basis of morphology and histopathological features:
• Chromoblastomycoses are pathognomically characterised by the presence of rounded copper-coloured 
structures with cross-walls called sclerotic bodies and cause nodular and cauliflower-like subcutaneous 
lesions. 
• Pheohyphomycoses are characterised by moniliform and toruloid (yeast-like) hyphae which may be 
cutaneous, subcutaneous or deep lesions e.g. cerebral, pulmonary, bone or spinal abscesses. 
• Eumycetomas usually involve exposed areas of the body and are distorted nodular lesions giving rise to 
draining sinuses with granules. Granules are frequently dark coloured, and microscopically show hyphal forms. 
Chromobalstomycoses
Nodular and 
cauliflower-like 
subcutaneous 
lesions containing 
sclerotic bodies 
Eumycetomas
Chronic tumour-like 
lesion with draining 
sinuses and granules 
in pus
Dematiaceous fungal infections
Disseminated
Allergy
Yeast-like cells and 
varied hyphal forms
Fig. 3.5.2-3 Copyright © American Society for Microbiology, [J Clin Microbiol 51, 2013,3167, doi:  10.1128/JCM.01604-12]
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Fungal osteomyelitis and arthritis
Fungal osteomyelitis and arthritis, 
10% KOH wet mount smear
A 20-year-old patient presented with a swollen and 
discharging sinus over the medial side of right foot. 
Radiograph shows a soft tissue swelling overlying the  
big toe along with sclerosis and destruction of the 
proximal phalanx as well as the metatarsophalangeal 
joint (arrow). The appearances are consistent with  
fungal osteomyelitis and arthritis.
Septate hyphae in tissue from the patient with 
mycetoma. (x40)
Fig. 3.5.2-
11 Fungal 
osteomyelitis 
and arthritis. 
Fig. 3.5.2-12 Fungal osteomyelitis and arthritis, 10% KOH wet 
mount smear.
Fig. 3.6-11 Fig. 3.6-12
Identification 
• Dematiaceous molds are differentiated based on the rates of growth (slow growing versus rapidly growing) and 
then further divided based on the origin of conidia:
• Holoblastic: conidia arise with all layers of cell wall from conidiophores.
• Enteroblastic: conidia arise from internal layer of conidiophore by bursting out of the outer cell wall.
• Thallic: conidia form by breaking off from the main hyphae after lysis of the separating cells.
• Common dematiaceous fungi can be identified using the simple schema shown.
Sympodial 
(e.g. Bipolaris, 
Fonsecaea, 
Alternaria)
Synchronous (e.g. 
Aureobasidium 
pullulans, 
Cladosporium, 
Cladophialophora 
bantianna)
Arthroconidia (e.g. 
Neoscytilidium)
Phiallidic (e.g. 
in chains: 
Scopulariopsis)
Thallic 
Enteroblastic 
Holoblastic 
Phiallidic (e.g. Phialophora)Annelidic (e.g. Exophiala)
Holoblastic (e.g. 
Cladophialophora 
carrionii)
Slow growing (<5mm in 14 
days)
Rapidly growing (2-5 days)
Black fungus
Black fungus
Rapidly growing (2-5 days)
Holoblastic 
Synchronous 
(e.g. Aureobasidium 
pullulans, 
Cladosporium spp., 
Cladophialophora 
bantianna)
Sympodial (e.g. 
Bipolaris spp., 
Fonsecaea spp., 
Alternaria spp.)
Arthroconidia 
(e.g. Neoscytilidium spp.)
Thallic 
Holoblastic 
(e.g. Cladophialophora 
carrionii)
Annelidic 
(e.g. Exophiala spp.)
Phiallidic 
(e.g. Phialophora spp.)
Slow growing (<5mm in 14 days)
Alternaria spp., LPCB wet mount preparation
Alternaria species
Alternaria is one of the most common rapidly growing black molds found in the environment and soil. It is 
frequently isolated from fungal polyps, sputum samples, nails of patients with onychomycosis and other infections 
due to traumatic implantation e.g. keratitis, soft tissue infections and even brain abscesses. 
Culture on SDA leads to rapidly growing colonies (>5 mm in 5 days) that are olivaceous green at the front and 
black on reverse side (not shown). Initially, colonies are flat and then become fluffy with a white downy border.
Microscopically, the tapering conidia arise in chains and have both transverse and vertical septae giving a 
muriform appearance. The conidiation is considered sympodial as conidia arising from the same conidiophore 
are seen in various stages of development. (x40), (x10) (see arrow)
Fig. 3.5.2-
13 A and 
B. Alternaria 
spp., LPCB 
wet mount 
preparation.
Fig. 3.6-13 Fig. 3.6-14
Diagnosis of Fungal Infections (Clinical Lesions, Microscopic Examination and Culture)
Madura (mycetoma) foot A close-up view of mycetoma foot
Patient presented with a 1-year history of slowly 
enlarging painless nodules on foot after minor trauma. 
Later these papules and pustules formed draining 
sinuses discharging grains.
The infection can permanently scar and damage skin, 
subcutaneous tissues and bones. This patient was 
treated with debulking and reconstructive surgery by a 
plastic surgeon combined with itraconazole and 
rifampicin therapy for 2 years.
Fig. 3.5.2-
9 Madura 
(mycetoma) 
foot. 
Fig. 3.5.2-10 
A close-
up view of 
mycetoma 
foot. 
Fig. 3.6-9 Fig. 3.6-10
Muriform elongated conidia of Alternaria spp. in 
chains (using objective lens x10)
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Curvularia species
Curvularia is a saprophytic rapidly-growing black mold with similar distribution to Alternaria, Drechslera and 
Bipolaris spp. Human infections with Curvularia spp. are rare, but can lead to fatal cerebral disease.
Colonies are fluffy in texture and appear a deep black both on front and reverse, giving off a bluish hue as they 
age (not shown).
Curvulria spp., LPCB wet mount preparation
The thallus consists of 
dark septate hyphae with 
conidia arising 
sympodially from the 
conidiophore. Conidia 
have transverse septae 
with 3-5 cells. Identifying 
characteristic is a large 
and darker central cell 
due to which the conidia 
appear curved or 
geniculate (like a bent 
knee). (x40)
Fig. 3.5.2-
15 Curvulria 
spp., LPCB 
wet mount 
preparation.
Fig. 3.6-16
Diagnosis of Fungal Infections (Clinical Lesions, Microscopic Examination and Culture)
Exserohilum species
A rapidly growing black mold, Exserohilum gained fame during the 2012 iatrogenic fungal meningitis outbreak 
when a batch of epidural steroid injections was found to be contaminated with its spores. Clinical niche otherwise 
is similar to other saprophytic melanised fungi with sinusitis as the main manifestation. 
Colonies have fluffy grey surface on front and a dark reverse side (not shown).
Exserohilum spp., LPCB wet mount preparation
Hyphae are septate and 
pigmented. Holoblastic 
conidiation gives rise to 
elongated conidia with 
8-12 cells divided by 
transverse walls and 
ending in a prominent 
hilum. (x40)
Fig. 3.5.2-16 
Exserohilum 
spp., LPCB 
wet mount 
preparation.
Fig. 3.6-17
Cladosporium spp., LPCB wet mount preparation
Cladosporium species
Cladosporium is an environmental contaminant that can cause serious disseminated haematogenous infections. 
Colonies grow slowly and mature within 3 weeks. Colour of colonies varies from dark grey, grey green to dark 
green on front, and appears black on reverse surface (not shown). A distinctive feature is the species inability to 
grow at temperatures above 37oC.
On microscopy hyphae 
are dark and septate, 
conidiophore have 
medium to long chains of 
conidia. Conidia are 
brown, smooth, oval with 
scar of attachment. 
Maximum growth 
temperature of the 
colonies is 35-37oC. 
Conidia are holoblastic 
and can be dislodged 
easily and resemble 
shields. (x40)
Fig. 3.5.2-17 
Cladosporium 
spp., LPCB 
wet mount 
preparation.
Fig. 3.6-18
Cladophialophora species 
Cladophialophora is a mold that is an environmental contaminant and can cause serious disseminated 
hematogenous infections.
Cladophialophora bantiana
C. bantiana has a tropism for central nervous system and infection results in brain abscess. 
Colonies growth rate is slow and mature in 2 weeks. Colour of colonies varies from olive green to brown to black; 
reverse is black (not shown). The distinct feature of this species is thermotolerance and ability to grow at 42oC.
On microscopy dark septate hyphae are seen. Conidiophores are long with unbranched chains of pale brown, 
oval conidia (not shown). No scar of attachment is seen in conidia. 
Microscopically, they 
both have elongated 
conidia with transverse 
septae with 3-6 cells. 
Conidia are holoblastic 
and sympodial. Bipolaris 
species have more 
abundant conidia arising 
at the tips of 
conidiophores along their 
long axis while Drechslera 
species have fewer 
conidia arising at right 
angles to the 
conidiophores. (x40)
Fig. 3.5.2-14 
Bipolaris and 
Drechslera 
spp., LPCB 
wet mount 
preparation.
Bipolaris spp., LPCB wet mount preparation Fig. 3.6-15
Bipolaris and Drechslera species
Rapidly growing black molds found in the environment. Similar to Alternaria species in clinical relevance, they 
are commonly isolated from nasal sinuses, respiratory specimens and wounds contaminated with environmental 
debris. To differentiate between Bipolaris and Drechslera, perform the germ tube test and observe germination of 
the hyphae from the hilum: 
• Bipolaris – germ tubes arise along the long axis of the conidia.
• Drechslera – germ tubes arise at right angle to the long axis of the conidia.
Both show fluffy colonies with olivaceous black surface on the front and a dark brown tinge on reverse side (not 
shown).
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Sporothrix schenkii
S. schenkii is a dimorphic fungus with a global distribution as an environmental contaminant. It is a known agent 
of sporotrichosis, a subcutaneous fungal infection that may involve lymphatic vessels, lymph nodes, bones and 
joints, as well as disseminated infection in immunosuppressed patients. 
Colonies grow rapidly and mature in 5-7 days. Characteristics vary depending on incubation temperature:
• At 25-30oC initial colonies are white to grey that become black with age with a grey to black reverse. Colonies 
can be flat, leathery or wrinkled (not shown). 
• At 35-37oC colonies are cream and yeast-like and may require repeated subcultures to obtain good yeast 
phase (not shown). Sometimes conversion to yeast form is incomplete and therefore an inhibited and slower 
growth similar to that at 25-30oC is seen. 
Dark septate hyphae are 
seen. Conidiophores 
have medium length 
chains branching after 
10-15 conidia. Conidia 
are brown, smooth, and 
oval with scar of 
attachment. (x40)
Fig. 3.5.2-18 
C. carrionii, 
LPCB wet 
mount 
preparation.
C. carrionii, LPCB wet mount preparation Fig. 3.6-19
On microscopy hyaline, 
septate hyphae with 
delicate conidiophore are 
seen. Conidia are oval 
and appear on the apex 
of conidiophore in a 
rosette-like or star-like 
pattern. Later developed 
conidia are dark and 
develop singly along the 
hyphae. Microscopy of 
yeast form exhibits 
round, oval or cigar-
shaped yeast cells. (x10)
Fig. 3.5.2-19 
S. schenkii, 
LPCB wet 
mount 
preparation.
S. schenkii, LPCB wet mount preparation Fig. 3.6-20
Exophiala spp., front view of culture on SDA agar
Exophiala species
Exophiala is a slow-growing annelidic fungus found in decaying wood and soil. Common cause of subcutaneous 
infections and cerebral mycosis.
Young cultures show 
yeast-like appearance 
that convert to mold form 
with time.
Fig. 3.5.2-
20 Exophiala 
spp., front 
view of 
culture on 
CMT agar.
Exophiala jeanselmei
Colonies are olive green to greenish black to black with a black reverse (not shown). Maximum growth 
temperature is 37oC. Does not grow at higher temperature. Matures in 2 weeks. 
Fig. 3.6-21
Septate hyphae with 
conidiophores, which are 
cylindrical with needle-
like projections. 
Numerous brownish 
conidia that accumulate 
in groups at the tips of 
conidiophores or along 
the hyphae. (x10)
Fig. 3.5.2-21 
E. jeanselmei, 
LPCB wet 
mount 
preparation.
E. jeanselmei, LPCB wet mount preparation Fig. 3.6-22
CAUTION: C. bantiana is a Hazard Group 3 pathogen and can be transmitted to health care workers through 
respiratory route. Colonies should be handled in a biosafety cabinet and slide cultures should not be performed.
Cladophialophora carrionii
C. carrionii mainly causes chromoblastomycosis. Colonies grow slowly and mature within 3 weeks. Colour of 
colonies varies from dark grey, grey green to dark green with a black reverse (not shown). Maximum growth 
temperature of the colonies is 35-37oC.
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E. dermatitidis, LPCB wet mount preparation
Exophiala dermatitidis
On culture, colonies are olive grey to greyish black with a dark reverse. May have a diffusible brown pigment. 
Maximum growth temperature is 42oC and maturity takes 3-4 weeks (not shown).
Abundant budding yeast like cells with few septate hyphae with conidiophores that are flask-shaped and lack a 
collarette. Few brownish conidia are seen that accumulate in groups at the apex or down the sides of 
conidiophores or along the hyphae. (x10)
Fig. 3.5.2-22 
E. dermatitidis, 
LPCB wet 
mount 
preparation.
Fonsecaea pedrosoi 
F. pedrosoi is the most common cause of chromoblastomycosis worldwide. Single isolate may have two to three 
types of conidiation.
Conidiation types includes Fonsecaea type (conidiophore: erect, septate and sympodial with distal end swollen; 
conidia: single-celled; long chains: not formed); Rhinocladiella type (conidiophore: erect, septate and sympodial 
with distal end swollen; conidia: single-celled either on the distal end of conidiophore or along the side); 
Cladosporium type (conidiophore: erect; conidia: scarred and in short chains; shield cells seen); and Phialophora 
type (vase-shaped phialides with terminal collarettes having oval conidia). 
Fig. 3.6-23
Day 5. Colonies are dark green, grey or black, flat and 
velvety. Reverse view is black.  
Culture on SDA shows colonies that grow slowly and 
mature in around 14 days.
Day 15. Colonies are slow growing.
F. pedrosoi, front view of culture on SDA F. pedrosoi, front view of culture on SDAFig. 3.6-24 Fig. 3.6-25
F. pedrosoi, LPCB wet mount preparation F. pedrosoi, LPCB wet mount preparation
Pigmented hyphae with dark conidia. Single isolate 
may have two to three types of conidiation. In this slide, 
fonsecaea, rhinocladiella and Cladosporium conidiation 
are seen. (x40)
Close-up view shows fonsecae conidia. (x40)
Fig. 3.6-26 Fig. 3.6-27
Rhinocladiella mackenziei
R. mackenziei is a mold commonly found in arid regions of Middle East, Afghanistan, Pakistan and India. The 
majority of infections occur in immunocompetent individuals. In Pakistan, R. mackenziei has been as an agent of 
cerebral phaeohyphomycosis, which has an extremely low survival rate.
R. mackenziei, front view of culture on SDA R. mackenziei, LPCB wet mount preparation
Growth is dark grey-brown to black. Colonies are slow 
growing and mature in 3-4 weeks. Some isolates do not 
grow up to 4 weeks and grow initially as black 
discolouration of media. Reverse is black.
On microscopy, hyphae are pigmented, septate with 
dark brown oval conidia. Conidiation is poor on first 
isolation and develops later after subsequent 
subcultures. The characteristic diagnostic feature is 
the Rhinocladiella type sporulation that gives the 
“mickey mouse appearance”: multiple budding with 
thick-walled cells. This is not seen with any other type 
of sporulation even after prolonged incubation. (x40)
Fig. 3.5.2-
24 A. R. 
mackenziei, 
front view of 
culture on 
SDA.
Fig. 3.5.2-
24 B. R. 
mackenziei, 
LPCB wet 
mount 
preparation.
Fig. 3.6-28 Fig. 3.6-29
Fig. 3.5.2-28 Copyright © Oxford University Press, [Clinical Infectious Diseases 52, 2011, 213-217, doi:  10.1093/cid/ciq114]
Fig. 3.5.2-29 Copyright © Oxford University Press, [Clinical Infectious Diseases 52, 2011, 213-217, doi:  10.1093/cid/ciq114]
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Neoscytalidium dimidiatum
Mold commonly found in tropical and subtropical region environments, causing infection secondary to trauma. 
Results in dermatomycosis, onychomycosis and, very rarely, systemic infections. 
N. dimidiatum, front view of culture on SDA N. dimidiatum, LPCB wet mount preparation
Colonies grow fast and mature in 3 days. Surface is 
initially white but rapidly changes to dark brown or  
black. Reverse is black. Woolly in texture and may  
fill the air space of the culture plate.
Septate hyphae without conidiophore are seen. Dark 
brown wider and hyaline narrow arthrospores are seen 
in abundance. These arthroconidia are either one-
celled or two-celled separated by a thick septum. 
Shape of arthrospores varies from rectangle, square, 
oval, or barrel shaped. There are no empty cells 
between consecutive arthrospores. (x40)
Fig. 3.5.2-
25 A. N. 
dimidiatum, 
front view of 
culture on 
SDA.
Fig. 3.5.2-
25 B. N. 
dimidiatum, 
LPCB wet 
mount 
preparation.
Fig. 3.6-30 Fig. 3.6-31
Chaetomium species
Chaetomium is a mold found in environment particularly water-damaged buildings and can result in serious life-
threatening systemic infections. 
On culture, colonies grow fast and mature within 3-5 days. On front, initially colonies are white but with aging turn 
pale buff, olive green and then greyish green. Reverse is buff (may be brown to black) with sometimes a green, 
yellow or red diffusible pigment (not shown).
Close-up view of an ascocarp, LPCB wet mount preparation
Ascocarp is a large 
brown oval structure with 
unbranched wavy and 
dark-coloured hyphae 
radiating from it. They 
contain asci that are 
club-shaped and contain 
4-8 spores. Ascospores 
are lemon-shaped, 
brown and single-celled. 
(x40)
Fig. 3.5.2-26 Close-up view of an ascocarp, 
LPCB wet mount preparation.
Fig. 3.6-32
Phoma spp., LPCB wet mount preparation
Close-up view of ostiole, 
LPCB wet mount preparation
Phoma species
Phoma species is typically an environmental contaminant causing infections in plants but can cause rare fatal 
disseminated fungal infections in humans. On culture on SDA, colonies are fast-growing and mature within 3-5 
days. On gross examination, colonies are reddish to greyish brown on front and brown to black on reverse (not 
shown). Sometimes a reddish brown diffusible pigment is seen.
On microscopy, septate hyphae are seen. A prominent 
feature is the presence of large pycnidia or fruiting  
bodies that are dark and oval to round with an opening 
called ostiole. (x40)
Through this opening, colourless ovoid single-celled 
conidia are released. (x100)
Fig. 3.5.2-
27 A. Phoma 
spp., LPCB 
wet mount 
preparation.
Fig. 3.5.2-27 
B. Close-
up view of 
ostiole, LPCB 
wet mount 
preparation.
Fig. 3.6-33 Fig. 3.6-34
Hormonema dematioides
H. dematioides is a yeast-like fungus found in environment that causes rare but clinically-significant infection in 
immunosuppressed patients. 
On culture on SDA, colonies mature rapidly in 3-5 days. Initial colonies are buff and smooth with a pink tinge (not 
shown). On extended incubation, colonies are brownish black on front and black on reverse. 
On microscopy young 
colonies have abundant 
yeast-like cells. 
Microscopy of older 
colonies exhibit two 
types of hyphae: 
a. hyaline and thin-
walled with conidia 
arising directly, and 
b. dark and thick-
walled that break into 
arthroconidia. The 
pigmented hyphae also 
bear conidia. (x40)
Fig. 3.5.2-
28 H. 
dematioides, 
LPCB wet 
mount 
preparation. H. dematioides, LPCB wet mount preparation Fig. 3.6-35
Fig. 3.5.2-30 Copyright © American Society for Microbiology, [J Clin Microbiol 51, 2013,3167, doi:  10.1128/JCM.01604-12]
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P. werneckii, LPCB wet mount preparation
Phaeoannellomyces werneckii
Also known as Hortaea werneckii, this fungus is found in soil, compost and wood, and is a causative agent of tinea 
nigra. 
On culture, colonies are slow growing and can take up to 3 weeks to mature. Initial colonies are yeast-like. Growth 
on front is olive-black and black on reverse (not shown).
Microscopy of young 
colonies reveals pale or 
dark brown yeast-like 
cells with a central 
septum. These cells are 
pointed at one end and 
rounded at the other 
end. Older colonies 
develop septate hyphae 
with thick brown walls. 
(x10)
Fig. 3.5.2-29 
P. werneckii, 
LPCB wet 
mount 
preparation.
Fig. 3.6-36
Madurella species
Madurella is a common soil fungus found in tropical regions and causes infections secondary to trauma. Infection 
results in mycetomas localised to cutaneous and subcutaneous tissues, fascia and bone. On culture, colonies are 
slow growing and may take up to 14 days to mature. 
Madurella mycetomatis
Culture on SDA produces colonies that are cream, yellow to olive brown in front, and on reverse brown with a 
diffusible pigment (not shown). 
On microscopic examination, septate hyphae are visible that are usually sterile. At times, culture on CMT agar 
produces phialides that bear small oval to round conidia (not shown).
Madurella grisea
M. grisea, front view of culture on SDA M. grisea, microscopic examination
Colonies are folded and dark brown to black. On reverse, 
colonies are dark. A diffusible pigment may be seen. 
Colonies do not grow at 37oC.
Dark and wide septate hyphae. The hyphae are made 
of chains of round cells. Apart from these hyphae, 
thinner septate hyphae are also seen. These hyphae 
are usually sterile. Chlamydoconidia are rarely 
produced. (x40)
Fig. 3.5.2-30 
A. M. grisea, 
front view of 
culture on 
SDA.
Fig. 3.5.2-30 
B. M. grisea, 
microscopic 
examination.
Fig. 3.6-37 Fig. 3.6-38 4ANTIFUNGAL SUSCEPTIBILITY TESTING
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Antifungal Susceptibility Testing
Joveria Farooqi
Improvements in diagnostic tools have allowed an increasing number of invasive fungal infections to be 
diagnosed and treated with antimicrobials. At the same time, resistance to antifungals has emerged as a 
significant problem. Susceptibility to antifungals is well-studied for the yeast form with established clinical 
breakpoints.
In the clinical setting, three main families of antimycotics are used to treat infections: polyenes (amphotericin B, 
nystatin and natamycin); azoles (itraconazole, fluconazole, voriconazole, posaconazole and isavuconazole); and 
echinocandins (caspofungin, micafungin and anidulafungin).
Currently, standardised methodology for susceptibility is available for Candida species, Cryptococcus species, 
and non-dermatophyte molds. However, clinical breakpoints are available for only certain Candida species and 
have not yet been established for Cryptococcus species and molds. Susceptibility testing for yeasts can be 
incorporated in clinical reporting as its performance is no more difficult than that of bacteria. Maintaining sterility 
during testing and quality control for molds, on the other hand, are much more exacting tasks than for yeasts.
Susceptibility Testing for Candida species
In this chapter we have opted to solely focus on the methods to determine antifungal susceptibility against the 
Candida species considering the availability of definitive data — both CLSI and EUCAST have standardised disc 
diffusion and broth microdilution methodologies and breakpoints (clinical or epidemiological cut-offs).
Disc Diffusion Method
On an agar plate, colonies of fungal isolate are tested against antifungals. Clear zones around each disk (zones of 
inhibition) are measured to determine susceptibility and MICs. 
Prerequisites 
• Müller-Hinton agar plate supplemented with 0.5 µg/ml methylene blue and 2% dextrose.
• Glass tube with 0.85% sterile saline solution.
• Isolated yeast colonies from a 20-24 hours old culture grown on an antibiotic-free medium (SBA, SDA or PDA).
Procedure
• Make a suspension of 0.5 McFarland turbidity in 0.85% saline with a few colonies from a 20-24 hours old 
culture of Candida species on an antibiotic-free medium.
• Soak a sterile cotton swab in the suspension, rolling it along the glass wall of the tube to get rid of the excess 
moisture.
• Make lawn on MHA supplemented with methylene blue and 2% dextrose.
• Using sterile forceps place antifungal discs on the agar surface and incubate the plates at 35+1°C for 20-24 
hours in ambient air. 
• Measure zone diameters for each antifungal:
• For azoles measure zones from where there is 50-80% inhibition of growth. 
• For caspofungin measure zones from where there is complete inhibition of growth.
• Interpret readings according to the specific Candida species (Table 4.1).
• Compare with QC ranges for the recommended ATCC strains (Table 4.2).
Antifungal Susceptibility Testing
Minimum Inhibitory Concentration Method – E-test 
A plastic strip is impregnated with gradually decreasing concentration of a particular antibiotic. The method is 
convenient but costly since a new strip is needed for each antibiotic. Breakpoints of broth microdilution method 
are applied, although not yet approved for E-test.
Prerequisites 
• RPMI agar with phenol red and 2% dextrose. For RPMI media preparation, refer to EUCAST guidelines on 
antifungal susceptibility testing.
• Glass tube with 0.85% sterile saline solution.
• Isolated yeast colonies from a 20-24 hours old culture grown on an antibiotic-free medium (SBA, SDA or PDA).
Procedure
• Make a suspension of 0.5 McFarland turbidity with a few colonies from a 20-24 hours old culture of Candida 
species on an antibiotic-free medium in 0.85% saline.
• Soak a sterile cotton swab in the suspension, rolling it along the glass wall of the tube to get rid of excess 
moisture.
• Make lawn on RPMI agar.
• Use sterile forceps to place E-test strips on the surface of the agar taking care not to move the strip and 
ensuring there are no air bubbles between the strip and the agar surface.
• Incubate the plates at 35+1°C for 20-24 hours in ambient air.
• For azoles measure MICs where there is 50-80% inhibition of growth. 
• For amphotericin B and echinocandins measure MICs where there is complete inhibition of growth.
• Interpret readings according to specific Candida species (Table 4.1).
• Compare with QC ranges for the recommended ATCC strains (Table 4.2).
Minimum Inhibitory Concentration Method – Broth Microdilution
This is considered gold standard in antifungal susceptibility testing. Detailed methodology is beyond the scope of 
this book but is available in CLSI M24-A4 and EUCAST (online). Commercial variations of the conventional broth 
microdilution method are also available from various manufacturers. These products are user-friendly and results 
are comparable to the standard method.
Fig. 4.1: Commercially available colourimetric broth microdilution assay, 
YeastOne Sensititre®, for antifungal susceptibility testing of Candida and 
Cryptococcus species. Growth of yeast in the wells changes the colour of 
alamar blue to pink, making MIC reading easier.
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Table 4.1: Interpretation of zone diameters and minimal inhibitory concentration according to CLSI
Species Antifungal    Susceptible  Susceptible  
 dose-dependent/ 
 intermediate
    Resistant Non-susceptible
 ZD
(mm)
 MIC
(µg/ml)
 ZD
(mm)
 MIC
(µg/ml)
 ZD
(mm)
 MIC
(µg/ml)
 ZD
(mm)
 MIC
(µg/ml)
C. albicans
C. tropicalis
C. parapsilosis
Fluconazole 25µg ≥19 ≤2 15-18 4 ≤14 ≥8 - -
Voriconazole 1µg ≥17 ≤0.12 14-16 0.25-0.5 ≤13 ≥1 - -
C. albicans
C. tropicalis
Caspofungin 5µg ≥11 ≤0.25 - 0.5 - - <11 ≥1
C. parapsilosis
C. guilliermondii
- ≤2 - 4 - 8 - -
C. glabrata Fluconazole 25µg - - ≥15 ≤32 ≤14 ≥64 - -
Voriconazole 1µg ≥17 ≤1 14-16 - ≤13 >1 - -
Caspofungin 5µg ≥11 ≤0.12 - 0.25 - - <11 ≥0.5
C. krusei† Caspofungin 5µg ≥11 ≤0.25 - 0.5 - - <11 ≥1
Voriconazole 1µg ≥17 ≤0.5 14-16 1 ≤13 ≥2 - -
 All species Fluconazole 25µg ≥19 ≤8 15-18 16-32 ≤14 ≥64 - -
Voriconazole 1µg ≥17 ≤1 14-16 2 ≤13 ≥4 - -
Caspofungin 5µg * ≥11 ≤2 - - - - <11 >2
Amphotericin10µg^ - ≤1 - - - - - ≥2
†Do not report fluconazole for C. krusei due to inherent resistance. *All species except for C. parapsilosis and 
C. guilliermondii. ^C.lusitaniae rapidly develops resistance to amphotericin B on therapy; do not report for  
C. lusitaniae.
Table 4.2: Quality control ranges for yeast susceptibility testing
Perform quality control every time a new batch of Müller-Hinton agar with methylene blue or RPMI agar is made.
Organism     Antifungal
(disc content in µg)
MIC range 
    (µg/ml)
Zone diameter 
        (mm) 
C. parapsilosis 
ATCC 22019
Amphotericin B 0.25-2.0 -
Fluconazole (25) 0.5-4.0 22-33 
Voriconazole (1) 0.016-0.12 28-37 
Itraconazole 0.12-0.5 -
Caspofungin (5) 0.25-1.0- 14-23 
C. krusei  
ATCC 6258
Amphotericin B 0.5-2.0 -
Fluconazole 8.0-64.0 -
Voriconazole (1) 0.06-0.5 16-25
Itraconazole 0.12-1.0 -
Caspofungin (5) 0.12-1.0 18-26
Antifungal Susceptibility Testing
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Antigen-based Tests for the Diagnosis of Fungal 
Infections 
Kauser Jabeen and Joveria Farooqi
Several successful attempts have been made to use non-culture and non-invasive approaches to diagnose fungal 
infections. Tests are available that can detect specific fungal antigens, the host antibody generated and large 
macromolecules specific to fungal pathogens. Reliability of results depends on the the microbial burden, time 
of testing (early versus late in disease process), immunocompetency of the host and the presence of underlying 
diseases or co-infections. Results must always be carefully interpreted in light of sensitivity and specificity of each 
test.
Cryptococcal Antigen Testing
This test is based on latex particle agglutination methodology. Latex particles labeled with antibodies specific to 
cryptococcal capsular antigen are mixed with patient specimens such as CSF and serum, and observed for any 
clumping. 
Procedure
• Instructions in the insert should be followed precisely. As with handling all clinical specimens, gloves should be 
worn while performing the test.
• Working with CSF
a. Take at least 0.5 ml (preferably 1 ml) of CSF in a sterile glass tube and boil it for 5 minutes.
b. Allow to cool. Label the disposable mixing card.
c. Prepare a 1:100 dilution by taking 25 µl of the heat-inactivated specimen and mixing with 2475 µl of sterile 
normal saline.
d. In four separate wells on a slide, place 25 µl of heat-inactivated specimen, 25 µl of the 1:100 dilution, and 25 
µl of positive and negative controls. Then add 25 µl of latex reagent in the four wells.
e. Mix well covering the entire reaction area and rotate at 100 rpm for 15 minutes.
f. Observe for agglutination (granularity), comparing it with positive and negative controls.
g. All positive test results should be doubly titrated and maximum titre showing agglutination reported.
• Working with serum
h. Add 300 µl of serum to a labeled glass tube and mix with 50 µl of pronase reactant, vortex and heat at 56°C 
for 30 minutes.
i. Follow steps b. to g. as above.
Interpretation
• Presence of clumping is indicative of the presence of cryptococcal antigen.
Errors
• False positives may occur with presence of silicone, glove latex, protein, Capnocytophaga species and yeasts 
such as Trichosporon species. 
• False negatives may occur with inadequate extraction or prozone phenomenon.
β-D-Glucan Detection
The antigen (1→3)-β-D-Glucan (BDG) is part of the fungal cell wall, not specific to any particular species. Its 
presence in serum indicates the release of the fungal cell wall antigen into the circulation, seen in invasive fungal 
infections. Detection of BDG concentration in serum is now established as one of the criteria for diagnosis of 
probable invasive mycoses.
Antigen-based Tests for the Diagnosis of Fungal Infections
Method
• An enzyme immunoassay (EIA) based technique is used to detect the antigen in patient samples, and 
methodology is according to manufacturer instructions. 
• Samples must be obtained very carefully by venipuncture using talc-free gloves.
• BDG is a very sensitive test as laboratory based reagent deterioration or contamination from environmental 
spores can greatly affect results. 
• It is advisable to run the test in triplicates before the performing technologist becomes proficient. Even for the 
most experienced technologist, the test must be run in duplicates at least.
Interpretation
• BDG cut-offs are well established for adults but not for paediatric patients as normal levels may be higher in 
children.
• Data for neonates and infants less than 6 months is lacking and therefore interpretation may be difficult. 
• The site of infection, encapsulation and the amount of BDG produced by certain fungi may affect its serum 
concentration. The antigen test results will most likely be negative if the infection is due to low producers 
of BDG, like Cryptococcus spp., zygomycetes (including Absidia spp., Mucor spp. and Rhizopus spp) and 
Blastomyces dermatitidis in its yeast phase.
• If BDG levels fall in the indeterminate zone, additional testing is recommended after assessing the patient’s risk 
of fungal disease. For high risk patients, sampling is recommended at least 2 to 3 times a week.
Table 5.1: β-D-Glucan interpretative cut-offs
Specimen Breakpoint/cut-off
Serum Negative <60 pg/ml
Indeterminate 60-80 pg/ml (repeat test recommended), 
Positive >80 pg/ml
Errors
• False positive results may be seen in patients on haemodialysis, receiving albumin or immunoglobulins, on 
certain antibiotics, exposed to glucan-containing gauze or talc, and those with mucositis. BDG may be tested 
3-4 days after the source has been removed.
• False negatives may be due to lipemic or hydrolysed blood samples (elevated triglycerides and bilirubin are 
inhibitory to the sample).
Galactomannan Detection
Galactomannan (GM) is an antigen found in the cell wall of Aspergillus species. Its detection by EIA has been in 
use for over a decade now as a non-invasive method to improve diagnostic sensitivity of invasive aspergillosis 
(IA). The test should never be used alone to confirm IA, and it should be interpreted in conjunction with clinical, 
radiological and culture findings as well as patient risk stratification.
Method
• EIA technique is used to detect the presence of GM antigen in recommended patient specimens, such as 
serum, bronchial lavage and CSF. 
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Interpretation
• An index of <0.5 is considered negative in all samples. However, galactomannan index (GMI) can also be used 
to assess response to therapy and rising or falling index may be interpreted as failure or response to therapy, 
respectively.
• A serum GMI value persistently >1.0 is considered a sign of therapeutic failure. 
Table 5.2: GMI interpretative cut-offs
Specimen Breakpoint/cut-off
Serum A single serum sample with GMI >0.7, or 2 consecutive samples with GMI > 0.5
Bronchoalveolar lavage GMI >1.0
CSF GMI >0.5
Errors
• False positives may be seen with laboratory contamination of water bath, ELISA plates or pipettes. Biological 
false positives may be seen with certain antibiotics (penicillins e.g. ampicillin, amoxicillin, amoxicillin-
clavulanate, piperacillin-tazobactam) and bacteraemia. 
• False negatives results are based on the extent of angio-invasion and dissemination as well as 
immunosuppressed state of the patient. MOLECULAR METHODS 
FOR THE DIAGNOSIS OF 
FUNGAL INFECTIONS
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Molecular Methods for the Diagnosis of Fungal 
Infections
Sadia Shakoor
Molecular approach to diagnostics is fast becoming the accepted standard for a number of bacterial and viral 
infections, especially for identification of isolates growing in pure cultures. Techniques used for identification 
include nucleic acid hybridisation probes, DNA sequencing, and peptide nucleic acid fluorescence in situ 
hybridisation (PNA-FISH). This chapter briefly describes the existing technologies for direct detection of fungal 
pathogens from clinical samples, their current status and prospects for further development.
Current Status
Despite being around for more than a decade, no recommendations for the use of molecular methods in fungal 
diagnostics have been made in recent guidelines. Molecular techniques combined with mass spectrometry 
procedures is a promising emerging diagnostic tool for fungal and bacterial identification alike. Although in 
the early development and validation stage, it is hoped that this will overcome the challenges faced by other 
molecular tests for fungal identification. The most important factor precluding recommendations remains difficult 
standardisation of tests (Box 6.1). After addressing these, and development of accurate tests, the next required 
step is FDA approval or CE marking before tests can be clinically validated and recommended as standard-of-
care. 
Despite these hindrances to the widespread adaptation of fungal molecular diagnostics, several commercial tests 
are available and have been demonstrated to be useful in diagnosis of fungal infections. 
Box 6.1: Challenges in development of accurate fungal molecular diagnostics tools
• Methods for fungal molecular diagnosis are not standardised 
• Extraction methods differ
• Primers used differ
• Cut-offs used differ for quantitative real time PCR
• Results vary depending on optimal time of sampling
• Patients on treatment continue to show positive results; cannot be used for prognosis
• Potential for false positive results
• Fungi are common environmental contaminants
• Colonisation versus infection, needs quantitative cut-offs
• Co-colonisation and co-infection with other fungi may be common confounders
Table 6.1: Molecular tests, sensitivities and specificities, and approval status
Fungal infection Test Current status Comments
Invasive 
Aspergillosis
Aspergillus real-time 
PCR
Not FDA approved but 
based on recommendations 
by European Aspergillus 
PCR Initiative (EAPCRI) 
and Aspergillus Technology 
Consortium, tests in clinical 
trials
•	 In bronchial specimens, 
sensitivity ~80% (comparable to 
galactomannan) while specificity 
~90%
•	 Combined use with 
galactomannan and β-D-Glucan 
detection increases sensitivity
Invasive 
Candidiasis
Candida real-time 
PCR (ITS1 for 
Candida spp.)
Not FDA approved •	 In plasma and serum samples, 
sensitivity >90%
Yeast Traffic Light 
(PNA-FISH)
FDA approved •	 Used for blood culture bottle 
positive for yeasts
•	 Can also differentiate between 
fluconazole resistant and 
susceptible species
Mucormycosis Real-time PCR Early development, several 
different studies but no single 
standardised test
•	 Used on blood, serum and 
bronchial specimens
Cryptococcosis As part of multiplex 
platforms in CSF 
samples
In process for FDA approval •	 Sensitivity not greater than 
antigen detection
•	 Advantage is that test can be 
run on a smaller volume and 
multiplexed with other pathogens
Pneumocyctosis MycAssay 
Pneumocystis,
real-time PCR
CE marking 2010 •	 22% increase in sensitivity as 
compared to the Calcofluor white 
stain method used on bronchial 
lavage specimens
•	 False positive rates may be 
high (46% in some studies with 
colonised patients)
Molecular Methods for the Diagnosis of Fungal Infections
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Quality Assurance
Imran Ahmed and Seema Irfan
Quality assurance aims to improve the accuracy, reliability, timeliness and reproducibility of information generated 
in a microbiology laboratory. Ultimately, it facilitates proper patient management, good laboratory practice, 
external accreditation and staff motivation. Consultants and senior technologists are responsible for quality 
management, and under their leadership, all staff should actively participate in QC programmes.
Quality assurance comprises of internal and external measures: 
• Internal quality assurance
• Monitors all phases of testing, including pre-analytical, analytical and post-analytical.
• Accomplished by assessing the quality of specimens, monitoring the performance of test procedures, 
reagents, media, instruments and personnel by reviewing test results and documenting the validity of the test 
methods.
• Identifies internal errors and helps in re-organisation of processes to ensure accuracy and reliability of 
results.
• External quality assessment
• Compares a laboratory’s testing performance to a source outside, such as a peer group of laboratories or a 
national reference laboratory. 
• Accomplished by proficiency testing, inter-laboratory rechecking or retesting of slides, and on-site 
evaluation.
• Identifies hidden errors in testing and ensures reproducibility of results. 
Box 7.1: Internal Quality Assurance versus External Quality Assessment
Internal Quality Assurance • Performed inside the lab
• Assesses accuracy and reliability of results
• Identifies internal errors
External Quality 
Assessment
• Performed inside and outside the lab
• Assesses reproducibility of results 
• Identifies hidden errors
Internal Quality Assurance
The basis is improving quality at each step in the laboratory workflow. Managers must invest time and resources 
to develop and implement standard operating procedures, hire competent staff, standardise tests, stock supplies 
and develop a record-keeping system. 
Quality Assurance
Standard Operating Procedures (SOPs)
• Maintain an SOPs binder in the laboratory that is accessible at all times to staff working on the premises.
• Develop and implement SOPs for every procedure performed in the laboratory using current guidelines and 
literature published in reputable journals and books. 
• To ensure that SOPs reflect current scientific knowledge and trends, a consultant and technical supervisor 
must review, revise, date and initial documents at least once a year.
Human Resource
• Based on the volume and complexity of work, a sufficient number of qualified supervisory and technical 
personnel must staff the laboratory.
• Document competencies of staff working in the laboratory at least twice a year. 
• Offer lab personnel access to continuing education programmes periodically.
• Maintain personnel file for documentation related to staff.
Specimen Collection and Transportation
• Ideally, collect specimens with sufficient coordination between laboratory staff and clinicians.
• Use a standardised specimen collection form to obtain relevant patient information from clinicians. Data 
collected should include at least the following: 
• Name (first and last)
• Unique identifier (such as medical record number or government-issued identification card)
• Age and sex
• Clinical history
• Site of specimen collection
• Time of specimen collection
• Information of other specimens submitted to laboratory
• Patient contact details
• Develop SOPs for each specimen collected and test run, and include at least the following information: 
• Transport medium
• Transport time
• Holding temperature during transport
• Availability and frequency of test in the laboratory (daily, bi-weekly, fortnightly, monthly)
• Reporting schedule (daily, bi-weekly, fortnightly, monthly)
Media, Reagents, Stains and Biochemical Reactions
• Apply labels on all containers clearly identifying the following:
• Name of culture media, solution or reagents
• Batch number
• Date of preparation
• Date of first in use
• Expiry date
• Check performance of media and reagents against QC strains (see Table 7.1).
• Maintain an inventory of mother stocks of QC organisms frozen at -70oC in potato dextrose slants for 
indefinite period of time. 
• Maintain a set of QC strains at room temperature and sub-culture every 3 months. 
• Draw fresh isolates from the mother stock frozen at -70oC once a year. 
• Media should only be made available once sterility checks have been performed. Contaminated lots of media 
and solutions should be discarded. Results of sterility check should be kept in the section.
• Check performance of all stains using positive and negative control slides. Record, initial and date results on an 
appropriate form. 
• Perform biochemical tests according to instructions outlined in the procedure manuals.
• Only report results for identification of organisms when the controls show expected result. 
• Immediately report unsatisfactory results to the laboratory supervisor. 
• Check all commercially prepared media, plates and tubes for cracks, clarity, excessive bubbles, hemolysis, 
unequal surface and filling, and visible contamination.
Pre-Analytical
• SOPs
• Laboratory personnel
• Specimen collection 
and transport 
Analytical
• Media and reagents
• Tests
• Results accuracy
Post-Analytical
• Reporting results 
• Recordkeeping
Figure 7.1: Overview of internal quality assurance
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• To determine sterility of media prepared in-house, follow these steps:
• At random, select 5% of plates prepared in each lot of media to be tested.
• Incubate each half of the plates selected at 25oC and 35oC for 3 days.
• Inspect those plates daily for contamination.
• If 5% or less of the total plates are contaminated, the lot is acceptable for use.
• If more than 5% of the total plates are contaminated, the lot is resampled. 
• If the resampled plates show greater than 5% contamination, the entire lot is assumed to be contaminated 
and should be discarded.
Reporting Results
• All laboratory reports must be reviewed and countersigned by the supervisor.
• Prior to finalising results ensure the following:
• No steps in testing were missed.
• No clerical errors were made while collecting specimen or running the test.
• Correct conclusions have been drawn.
• Review comments.
• Patient confidentiality was maintained.
• Clinicians are informed of panic results.
• Patient records will be maintained for at least 2 years. 
Archives and Recordkeeping
• Laboratory Staff are responsible for recording QC data on the appropriate forms.
• Supervisors (medical and technical) are responsible for monthly periodic review of the QC data.
• All QC records are required to be retained for a period of at least 2 years, including QC audits and QC 
indicators corrective action record.
• Weekly reviews by laboratory personnel (consultant and technical supervisor).
• Monthly reviews by laboratory head
Safety in Mycology Laboratory 
(see Chapter 8)
External Quality Assessment
External quality assessment is an important indicator of laboratory performance. During EQA, laboratory 
procedures, reagents, media, equipment and personnel are all checked. Depending on availability of time and 
resources, EQA can be performed using the following methods:
• External proficiency testing
• Unknown proficiency samples are sent to the laboratory for testing. Specimens should be processed within 1 
day of arrival. In order to keep impartiality with the specimens submitted for proficiency, all specimens are to 
be treated as patient’s specimens. 
• Final reports have to be reviewed and signed by the supervisor and director.
• A lab must maintain an average score of 80% to maintain licensure in that subspecialty area. 
• Rechecking or retesting
• Previously read slides and tests are re-read and re-analysed by a reference laboratory.
• On-site evaluation
• Done when external proficiency and rechecking/retesting methods are difficult.
Table 7.1: ATCC strains for quality control
For media prepared in-house, run with a new number each time. Otherwise the medium is exempt from quality 
control by user. 
Media Frequency of testing Positive control
ATCC
Negative control
ATCC
Sabouraud’s dextrose 
agar
With each batch C. albicans
10231 or 60193
T. mentagrophytes
9533
E. coli
25922
Potato dextrose agar With each batch A. fumigatus
9197
E. coli
25922
BiGGY agar With each batch C. albicans
10231
C. tropicalis
750
E. coli
25922
Malt extract agar With each batch A. niger
9642
C. albicans
10231
Un-inoculated Media
Aspergillus flavus and A. 
parasiticus agar
With each batch A. flavus
22547
A. niger
16404
Cornmeal Tween-80 With each batch C. albicans
10231
C. krusei
6258
Urease agar With each batch C. neoformans
66031
C. albicans
60193
Germ tube test Daily C. albicans
14053
C. tropicalis
66029
Mycosel agar 
(cycloheximide 
tolerance)
With each batch T. mentagrophytes
9533
C. albicans
10231
A. niger
16404
Dermatophyte test 
medium 
With each batch T. mentagrophytes
28188
A. niger
16404
Casein With each batch Nocardia asteroides 
(CDC B-2965) “Freddie”
Streptomyces griseus 
38904
Tyrosine With each batch N. asteroides 
(CDC B-2965) “Freddie”
S. griseus 
38904
Xanthine With each batch N. asteroides 
(CDC B-2965) “Freddie”
S. griseus 
38904
India ink Daily C. neoformans 
66031
C. albicans 
60193
Hair perforation test With each test T. mentagrophytes 
9533
T. rubrum 
28122
Quality Assurance
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Lactophenol cotton blue Daily Penicillium species and 
Aspergillus species
Solution without fungus
Calcofluor white stain With each test Aspergillus species and Candida 
species
Solution without fungus
10% KOH solution With each test Using a portion of a sputum 
specimen, ensure that the 
clinical material dissolves
Check the reagents prior 
to use. If cloudy, prepare 
new solution
Brain heart infusion 
(BHI) agar with 10% 
sheep blood slant
With each batch Histoplasma capsulatum Uninoculated slant
API 20C AUX With each new lot 
number
Trichosporon beigelii
2744771
C. glabrata 
2000040
SAFETY IN THE 
MYCOLOGY 
LABORATORY
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Safety in the Mycology Laboratory
Erum Khan
Safety in the mycology laboratory is crucial because of the potentially pathogenic fungi being studied as well 
as the hazardous nature of reagents, flames, glassware and procedures. For safety and protection, senior 
supervisory staff should develop biosafety guidelines and ensure that all workers are well-versed with them. 
Ideally, biosafety guidelines should be science-based, made available broadly and be updated based on real-time 
feedback. Individual labs should further tailor these recommendations based on their own experiences. 
Box 8.1: Definitions
Biorisk is any harm where the source is a biological material 
Biorisk assessment is an analysis of the severity and frequency 
of exposure to this harm
Biorisk management is the identification of biorisks, and steps 
towards its control and mitigation
Box 8.2: Five steps of risk assessment
• Identify potential hazards 
• Decide who is at risk 
• Assess likelihood of harm 
• Implement adequate precautions 
• Manage risks and hazardous situations
Pre-Analytical Phase Hazards
Risk Factors
• Patients with any active, latent, chronic or undiagnosed infections can be a source of disease, and sample 
collection, handling and transport should always be performed carefully.
Best Practices
• Only trained staff (phlebotomist, nurse or medical doctor) should collect samples – e.g. drawing blood, fine 
needle aspiration and punch biopsy – to avoid needlestick and prick injuries. 
• Always perform skin scrapings and nail drilling in an isolated room or area of lab to avoid creating contaminated 
aerosols. 
• Staff should wear personal protective equipment (PPE), such as mask, gloves and gown, as appropriate. 
Analytical Phase Hazards
Risk Factors
• The most common laboratory-acquired fungal infections are those caused by dimorphic fungi Blastomyces, 
Histoplasma and Coccidioides. Most (LAIs) are secondary to inhalation of conidia. 
• Ideally all specimens must be processed in a BSC observing safe practices. 
• If a BSC is not available, specimen processing should be performed in an area of the laboratory with minimum 
traffic to avoid aerosol generation.
• Staff processing specimens must wear proper PPE and must be competent to handle the specimen according 
to good laboratory practices.
Safety in the Mycology Laboratory
Box 8.3: Common modes of lab-acquired infections
• Parenteral inoculations with syringes and sharps 
• Splashes onto skin and mucus membranes
• Inhalation of aerosols
• Ingestion due to mouth pipetting or eating in laboratory
• Animal bites or scratches during animal studies
Best Practices
Highly Pathogenic Fungi
• Highly-pathogenic fungi include H. capsulatum, B. dermatitidis, Coccidioides immitis, C. posadasii, 
Paracoccidioides brasiliensis, P. marneffei, and C. bantiana, and must always be handled in a BSL-3 facility. 
• Avoid slide cultures and wet preparation of isolates that are suggestive of one of the above-listed pathogens. 
• Such pathogens can either be sent to reference labs or identified using molecular techniques to avoid 
exposure. 
Material Safety Data Sheet
• MSDS is an essential document that contains information about the chemical nature and safe handling i.e. 
storage and disposal guidelines of products in the laboratory.
• These documents are prepared by the manufacturers of the material and provide end-user information for 
possible hazardous outcomes in case of accidents or over exposure.
• As part of good laboratory practice, every chemical/hazardous material placed in the laboratory must be 
accompanied with an MSDS sheet. 
• Chemicals must be handled, saved and discarded as mentioned in these sheets. Data sets must be reviewed 
before chemical/hazardous material is used in the lab. 
• Always look at the MSDS, match the chemical on the container with the MSDS, be aware of the hazards, safe 
handling and storage of the chemical, as well as what to do in an emergency involving it.
Culture
• A complete risk assessment is recommended for an individual laboratory.
• Handle all cultures, especially molds (flamentous, fuzzy or cottony), in a Class II BSC placed in a separate room 
or a designated space in an open microbiology laboratory. 
• Petri plates (particularly those growing mold) must be sealed with porous tape to prevent accidental opening 
and spread of spores. 
• Cultures with yeast can be read on the open bench in a BSL-2 laboratory. However, if the isolate is suspected 
to be a dimorphic fungus (slow growing white or black molds) it must be shifted to Class IIA2 BSC for further 
manipulation or processing. 
• Never sniff a fungal culture to determine its odor. Even on a bacteriology work-station, plates containing molds 
should not be uncovered on the open bench. 
• Storage and transportation of filamentous molds to another laboratory must be done in slants with screw-cap 
tubes. Use of petri dishes is not recommended.
• Coccidioides spp. is the only fungus that is classified as a select agent. However, there are other highly-
pathogenic fungi that require special handling. 
Reagents and Media
• Potential risks and mitigations steps in mycology laboratory include but not limited to below mentioned 
reagents and activities.
• Potassium hydroxide
• KOH 10%-15% solution is corrosive and may cause burns or irritation to skin, eyes, and respiratory tract. 
• Avoid contact with eyes and skin, inhalation and ingestion. 
• Use of gloves and eye protection is recommended if there is a possibility of splashing or aerosol generation.
• Calcofluor white stain
• It is not hazardous and hence no special safety measures are required.
• Good hand hygiene using soap and water at the end of chemical handling is recommended. 
• In case of accidental eye contact, rinse eye well with water.
• If KOH is used with Calcofluor white stain, more stringent precautions must be taken. Always refer to MSDS 
for guidance.
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• Lactophenol cotton blue (Poirier’s blue) 
• It is the most commonly used stain in the mycology laboratory. 
• Chemically, LPCB is acidic and therefore avoid contact with skin, eyes and clothing. 
• The product is considered hazardous in larger amounts, i.e., toxic by inhalation and contact with the skin, 
and especially if swallowed.
• Handle large amounts of LPCB in a well-ventilated area. 
• India ink
• It is not a regulated hazardous waste in quantities used in clinical lab therefore no special personal protection 
is required under normal use conditions. 
• However, since yeast cells can remain viable, good hand hygiene and gloves are recommended when 
handling India Ink wet mounts.
• Gomori methenamine silver nitrate stain 
• Ingredients are toxic and corrosive therefore avoid contact with skin and eyes. 
• Large amounts must be handled with adequate ventilation system.
• Giemsa stain
• Giemsa stain is toxic by inhalation, absorption and ingestion due to its methanol content. 
Laboratory Design
• Laboratory design is fundamental to laboratory safety. Although there is no national standard requirement for 
area per person working in the laboratory, ideally, a minimum 5-foot space between the worker and any object 
behind her/him should provide enough room for movement between benches. 
• The mycology section should be separated from the rest of the laboratory by closable doors.
• Although not imperative, airflow should be preferably directed inward from the main laboratory into the 
mycology lab. 
• The section must also have a sink for hand washing. Bench-tops must be constructed of impervious materials.
• Mycology section must have restricted access, limited to staff only. 
Biosafety Level 3 Laboratory
• Since most common laboratory-acquired fungal infections are caused by inhalation of conidia of dimorphic 
fungi Blastomyces, Histoplasma, and Coccidioides, BSL-3 is preferred. 
• However, if BSL-3 facility is not available, use of BSC and respiratory precautions may be used with good 
laboratory practices.
Biosafety Cabinet
• Class II-A1 or II-A2 BSC is recommended for the diagnostic laboratory. 
• It is recommended that BSC should be installed in the laboratory away from walking paths and doors. 
• The BSC filter can get damaged at the glue joint or at the gasket if moved, resulting in dangerous leaks. Thus 
filter and cabinet integrity must be tested whenever the equipment is shifted.
• BSCs must be certified by trained professionals in accordance with ANSI/NSF Standard at time of installation 
and at least annually thereafter. In addition, recertification is recommended each time the unit is moved. 
Post-Analytical Phase Hazards
Risk Factors
• Generation of biohazard waste.
Best Practices
Disinfection
• All live cultures and waste generated must be autoclaved before discarding.
• If autoclaving is unavailable then fugal culture can be decontaminated by soaking the plates and tubes 
overnight in a fresh 1:10 bleach solution. The plates and opened tubes must be completely immersed overnight 
before discarding. 
• Ethyl alcohol (70%) has been reported as the most effective concentration for killing the tissue phase of           
B. dermatitidis, C. immitis, and H. capsulatum. 
• Chlorine-based disinfectants such as hypochlorite and house hold bleach (>0.5%) can also be used but these 
are corrosive and must be wiped effectively from metallic surface. 
Waste Management
• Laboratory must have a waste management plan that identifies and categorises waste as infectious and non- 
infectious at the site of waste generation. 
• Strategies must be in place to differentiate between categories of waste such as use of colour-coded waste 
bags. 
• All infectious waste must be either autoclaved or disinfected before it leaves the laboratory. 
• At BSL-3 labs all culture and stocks must be autoclaved before discarding. 
• For BSL-2 pathogens, cultures must be either disinfected or sealed in leak-proof containers to be incinerated, 
either on-site or at distant location, such as local government contractual agreements. 
Table 8.1: Common hazardous activities specific to mycology laboratory that can put workers at risk
Activity Potential 
hazard/route of 
transmission
Engineering control Administrative 
control/work practice
PPE Comments 
Respiratory 
samples 
inoculation
Aerosol 
generation, 
inhalation
BSL-2 laboratory, 
use of BSC 
Work inside BSC 
with splash shield 
Gloves, mask 
and laboratory 
coat
Risk of fungal, MTB 
and viral infections
Skin/tissue 
biopsies 
Sharp injury, 
percutaneous 
inoculation 
Use of protected 
sharps; puncture 
resistant sharp 
container
Work inside BSC 
with splash shield; 
immediate discard 
in punctured 
resistant bin
Gloves, mask 
and laboratory 
coat
If BSC is not 
available then clean 
bench at rear end of 
lab, skilled worker 
Sub-culture 
from blood 
culture bottle 
Sharp injury, 
percutaneous 
inoculation
Use safe sharps 
such as retractable 
needles; puncture 
resistant sharp 
container 
No recapping; 
immediate 
disposal of sharp 
in bin
Gloves, mask 
and laboratory 
coat
Do not over fill sharp 
discard container 
Centrifuge Aerosol 
generation, 
inhalation 
Use BSC, 
removable safety 
rotors, safety cups 
and plastic tubes
Load and unload 
rotors in BSC, 
and open lid 
when completely 
stopped; no glass
tubes
Gloves, mask 
and laboratory 
coat
Checks lids for wear 
and tear 
Smear/stain Aerosol slide 
warming, 
inhalation 
Use slide warmer Do not heat smear 
directly on flame 
Gloves and 
laboratory 
coat
Some stains are toxic 
and corrosive see 
above; avoid contact 
with skin and eyes 
Fungal wet 
mounts (KOH-
Calcofluor) 
Toxic 
inhalation 
and direct 
skin, mucus 
contact
Use well-ventilated 
room 
For storage of 
large volumes use 
fumes hood or 
properly ventilated 
room
Laboratory 
coat, glove, 
and mask 
when dealing 
with large 
volumes 
These are toxic 
and corrosive avoid 
contact with skin and 
eyes
Reading fungal 
culture plates
Aerosol 
generation, 
inhalation, 
direct 
inoculation
Use BSC for all 
molds; yeast can 
be processed on 
bench
Secure petri dish 
lid with adhesive 
tape
Laboratory 
coat, gloves 
and mask if 
handling mold 
outside BSC
Do not sniff fungal 
cultures at any point, 
do not open plate 
with mold on open 
bench
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Term Definition
Aleuriospore A fungal spore formed at the end of a hypha
Anamorph An asexual (imperfect) stage of fungus
Arthrospore A spore formed from fragmentation of a hypha into individual cells
Ascocarp A large fruiting body harboring asci, e.g. in Chaetomium spp.
Ascus A sac-like structure often formed in a fruiting body and usually contains 2-8 ascospores
Ascospore Sexual spore produced in an ascus
Aseptate A hypha without cross-walls or septa
Asynchronous Pertaining to conidiation; conidia are produced in succession from the same single fertile 
point; the conidia may form short chains or gather in loose clusters
Blastic Describes the spores formed by the enlargement of the spore-producing cell before the 
septum is produced
Blastoconidium A conidium formed by budding along a hypha, pseudohyphae or single cell as in yeasts
Chlamydospore A resting spore formed from the enlargement of an existing cell
Cleistothecia Closed fruiting body containing asci
Conidiogenesis Process leading to the production of conidia (spores)
Conidiophore A specialised cell or hypha on which spores are formed
Conidium An asexual spore
Coremia Compact cluster of erect conidiophores
Dysgonic Slow growing
Enteroblastic The formation of spores in succession from a spore-producing cell
Floccose Covered with woolly tufts or soft hair
Hilum Attachment scar, formed where the conidium was attached to the conidiophore
Holoblastic Production of a conidium with all layers of the mother cell wall
Hülle cells Large thick-walled multinucleated cells formed by some Aspergillus species
Hypha An individual filament that makes up the vegetative growth of a fungus
Macroconidia A large conidium (asexual spore) produced by fungi usually multicellular
Metula Cell or short branch on vesicle bearing phialides
Microconidia A small conidium (asexual spore) produced by fungi usually multicellular
Mold A filamentous fungus
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Mycelium A mass of hyphae (branching filaments) that make up the vegetative growth of a fungus
Ostiole A mouth or opening
Perithecium Large round or pear-shaped structure containing asci and ascospores that are released 
through an ostiole
Phialides Cell with terminal opening through which enteroblastic conidia are produced repetitively
Pseudohypha Chain of yeast cells that have been produced by budding and
have remained attached to one another forming a hypha-like filament
Pseudomycelium A mass of pseudohyphae
Pycnidium Large oval, round or flask-shaped fruiting body containing conidia; usually has an ostiole
Reflexive A hyphal branch that grows inwards towards the centre of the colony
Rhizoid A root-like branching hypha
Septate Having cross walls or septa 
Septa A cross wall in a fungal hypha or spore
Sporongiophore Specialised hyphal branch or stalk bearing a sporangium
Sporangium Closed sac-like structure in which asexual spores (sporangiospores) are formed by 
cleavage
Stipe Conidiophore bearing vesicle in Aspergillus
Sympodial Pertaining to the growth of a conidiophore; the conidia arising from the same conidiophore 
are seen in various stages of development. These conidiophores are typically geniculate in 
appearance
Synchronous Pertaining to conidiation; conidia are formed simultaneously, each arising from a separate 
fertile point; these points are often very close together, producing clusters of conidia 
(conidia in a cluster are in the same stage of development)
Synnemata Compact cluster of erect conidiophores
Teleomorph The sexual (perfect stage) of a fungus
Thallic Spores produced from an existing hypha
Yeast Unicellular budding organism
Zygospore A thick walled sexual spore produced by zygomycetes
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